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Clean Air Systems and the Operating Room

Where do
the pathogens
come from?
ohn Chamley, the orthopedic surgeon who
pioneered clean air systems in the operating
x>m, reduced post-operative infection rates
fter total hip procedures by a factor of seven
uring the nine year development of his now
imous “Greenhouse.” He could have rested on
lis accomplishment, but instead he pursued the
tubbom 1.3% infection rate that persisted and
y 1970 reduced it to 0.34%. His work uncovered
lany subtleties of infection by airborne pathoens in the surgical environment.
"he Chamley Greenhouse, isolating the operatlg team from the outer theatre by transparent
/alls and supplied with its own filtered air, proided a dramatic reduction of the post-operative
flection rate early in Mr. Chamley’s program
1959 to 1962). From the beginning, however, he
oncemed himself also with bacteria generated
iside the enclosure. Most obviously these
riginate from expired droplet nuclei and partiles dislodged from exposed skin and hair:
4r. Chamley’s gowning disciplines were strict,
saving only the eyes exposed.

) 1972Codbnan & Shurtleff, Inc.

^Trademark

T ess obvious was the possibility that epithelial
I j scales could migrate from the body surface
through the clothing, but Mr. Charnley conducted
tests which confirmed this source of bacteria
and specified cotton fabrics of special weave to
resist it. Further, he devised vacuum body
exhaust systems for each member of the team to
draw off both epithelial scales and expired
droplet nuclei.
The most recent improvement in post-operative
infection rate (1.3% to 0.34% from 1969 to 1970
—a four times reduction) is attributed by
Mr. Chamley tentatively to improved prevention
of scale migration through the textile of the gown.
nless controlled, airborne pathogens can
travel to the wound site not only from the
operating team, but from the air outside the
central zone and from unclean surfaces within
the zone. Enclosing walls are effective in prevent
ing the intrusion of particles, yet even they may
present a hazard if they accumulate dust on their
inner surfaces by electrostatic attraction, as
acrylic plastic tends to do. Glass is the preferred
material. The floor also stores contaminants, thus
a positive downward airflow is desirable to
prevent infectious dust from being swept up
into the wound.

U

T T o w do these criteria apply to a clean air system
J - X that has an enclosing air curtain instead of
solid walls? The pathogens originate from the
same sources, but the hazards are reduced by the
geometry of the air flow. The Allander* “Air
Curtain, in use at over 100 hospital installations
isolates the operating site from the outer theatre ’
by a four-sided high-velocity stream of filtered
air which entrains impinging particles downward
and outward. Inside the air curtain, a separate
supply of filtered air pushes downward and
away from the wound site carrying droplet nuclei
and epithelial scales into the entraining air
curtain. Contamination from the outer theatre is
likewise carried by the curtain air to exhaust
vents m the walls of the room. Since there are no
walls, there is no threat of dust accumulation
there. Particles cannot rise from the floor due to
the positive downward pressure.

^ ^ o d m a n s O.R. Systems Division recomV -' mends the only two clean air systems with
a substantial record of medico/engineering
results in surgical environments: the original
Chamley Greenhouse and the Allander Air
Curtain. Our exclusive representation of these
systems m the U.S. includes engineering plan
ning, installation assistance, and service. Your
inquiry will bring detailed information and assist
ance m evaluating the proper choice of clean
° ' R' Systems Division, C odm an&
bhurtleff, Inc., Randolph, Mass. 02368.

Codman

O.R. Systems Division

The Canadian Journal o f Surgery

8

FROM Professional
LOW FRICTION ARTHROPLASTY

Muller

%

V

Protasur
total hip
prostheses
Choice of sizes to meet all needs

As d es ig n e d and used by
Prof. M a u ric e E. M uller

No. 1.32.21—Standard stem, medium neck
(illustrated)
No. 1.32.31—Standard stem, long neck
No. 1.32.41—Narrow curved stem, short neck
No. 1.32.61 —Straight stem, short neck

Professor of Orthopaedic Surgery,
University of Berne,
Berne, Switzerland

•
•
•
•

Low-friction articulation
Wear-proof stem prosthesis
Durable acetabulum unit
32mm head reduces pressure
and wear on acetabulum unit
• Eliminates need to remove
greater trochanter
• Designed for easy insertion
• Eliminates need for expensive
inserting instruments
Literature Available

1. Reprint “Total Hip Prostheses",
by Prof. M. E. Muller. As published
in volume 72 of Clinical Orthopaedics
and Related Research
2. Complete catalogue of prostheses
and instrumentation
3. Price list of prostheses and
instrumentation
4. Colour sound film available:
Total hip replacement technique
by Prof. M. E. Muller

For special requirem ents—stainless steel prostheses
with longer necks, longer stems, and replacement
proximal third of fem ur. Available from stock.

CMW Bone Cement
The brand of cement
currently used by
both Muller and
Charnley.
Highly purified to
reduce allergenicity.
Kit includes sterile
powder, liquid and
optional radiopaque
material.

in . m

cement mm

CONTENTS OF THIS PACK ARE STERILE
S T E M im S

M m u m o

8Y

fOftMAtDtHVOE VAPOUR WITHIN THE PACK
« * mm-#./*-*
m *u*c«.<*’>

Available for immediate delivery from stock

uppi
jOinuted
[P r o fessionail (drtkopaedic Supplies
TORONTO

VANCOUVER

NEW YORK

3069 Universal Drive
Mississauga, Ontario
(416) 625-3381

32 West Fifth Avenue
Vancouver. B.C.
(604) 879-9451

467 Meacham Avenue
Elmont, Long Island
New York 11003
(516) 352-5440

September 1972

EDITORIAL COMMENT

285

y

>
>•

A

QU ILL ON SCALPEL This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

C. J. S. — ITS SIGNIFICANCE FOR
TOMORROW

r

As the decade o f the seventies moves
i inexorably forward, there is increasing
evidence that the practice o f medicine
and surgery will undergo many realign
ments between men and institutions
and between institutions and govern
ment. It is in this setting of change that
the nature of medical journals and the
many purposes o f publication must be
viewed, with particular reference to the
sphere of interest and purposes o f the
Canadian Jouvnal of Surgery.
In its July issue the Canadian Jour
nal of Surgery contained editorial com
ments by Dr. MacLean1 reappraising
the status o f the Journal, outlining
some o f today’s fiscal and adminis
trative problems, reviewing its format,
describing a desired liaison with some
o f the Canadian surgical societies and
pledging continued effort on the part
o f the Co-editors to enhance the distin
guished career o f the C.J.S. during the
coming years.
Although intense preoccupation with
surgical research has dominated the
efforts o f many surgical centres in the
past years, it now appears that the
promise o f tomorrow will intertwine
research effort with concerns related to
the delivery of surgical care and to in
creasing accountability to the public on
the part of our profession. Medical jou r
nals generally, and the Canadian Jour
nal of Surgery specifically, will thus
provide a forum where such concerns
can receive attention and where the
many problems o f health-care delivery
and health-manpower production may
be discussed by all the surgeons o f Can

ada. Publication o f results of treatment,
a sharing of new and old surgical ideas,
the introduction o f innovative methods
in general patient management (not
only in surgical operative techniques),
thus attain increasing significance, fo r
these elements will serve as a standard
o f reference for all Canadian surgeons.
Against this standard the quality o f
care, efficiency o f management and
analysis o f therapeutic outcome may be
measured.
It is appropriate at this time to ask
again the question, “ Why publish?” Is
this only a problem fo r academics,
phrased as “ publish or perish” or does
it have a place in the life of the up-todate surgeon? In answering this last
question in the affirm ative, we would
remember that publication carries dual
benefits— some fo r the author and some
fo r the reader and, as well, imposes on
editors the obligations o f ensuring that
what is published is relevant, appro
priate and current.
F or the author, publication enables
him to review his experiences and those
o f his colleagues, to evaluate critically
the management o f his cases and to
describe the outcome achieved in his
patients. It provides an opportunity to
propose novel methods and to publicize
innovative ideas with the knowledge
that scrutiny by an editorial board will
attempt to ensure quality o f perform 
ance, accuracy of reporting and validity
o f results. Thus the editorial discipline
required o f an author and the critical
approach needed to review surgical
practice or present new ideas serve the
author as a “ mini” medical audit o f his
own practice or an audit o f activities
within his institution.
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For the reader, in addition to provid
ing standards of reference, medical pub
lications have become the means of con
tinuing education. They give a reader
a means of assessing changing stand
ards of practice, changing methods of
treatment, changing concepts under
lying the surgical effort, and the stim
ulus to explore new approaches to the
rapy and derive new concepts of di
sease. Sharing the role of verbal presen
tation at meetings, medical journals
stand as the centerpiece of the continu
ing educational effort. It is this obliga
tion of publication which creates an
overriding imperative for the Journal
and which dictates the editorial format
of the Canadian Journal of Surgery.
Your editors and your editorial board
have pledged themselves to provide a
journal which fulfils the needs of con
tinuing education by “ audience parti
cipation” in the editorial pages and
which encourages further development,
expansion or exchange of ideas regard
ing the conduct and the context of sur
gical practice. During the past several
years review articles have attempted to
provide a continuous updating of the
current thought in frontier areas of
research and in new scientific develop

Vol. 15

ments which seem of importance to sur
geons. Pertinent research has been pub
lished as submitted, partly for the bene
fit of other workers in the same field
and partly to keep our readers aware
of efforts which may presage new
ideas and new thoughts that are apt to
impinge upon and modify the changing
scene of surgical practice.
Thus, your Co-editors propose to seek
connection with and sponsorship by
Canadian surgical societies, a speedy
publication of manuscripts, a readership
composed of all Canadian surgeons and
provide a forum for Canadian surgical
ideas. We recognize a continuing obliga
tion to provide a central resource for
continuing education, to permit the de
scription of innovative surgical prac
tice and to present new research ideas.
This is our goal and, if achieved, the
Canadian Journal of Surgery can in
creasingly become a forum where Cana
dian surgeons may discuss their areas
of interest, share ideas and present the
best outcomes of current surgical effort.
C. B arber M u eller
Reference
1. MacLean LD: C.J.S.— reappraisal (edi
torial). Can J Surg 15: 213, 1972
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H IS T O R Y O F SU R G E R Y
CAMPBELL B. KEENAN, D.S.O., M.D., C.M., F.R.C.S.rCl
1867 TO 1953
D. SCLATER L E W IS , M.D.,* Montreal, Que.
C a m p b e l l K e e n a n was one of the most
engaging characters on the staff of the
Royal Victoria Hospital, Montreal, at
the end of the First World War. One
of the senior surgeons, he had a consi
derable practice and was widely con
sulted by doctors of Italian and other
ethnic groups in the city. To the his
torically minded he was a man of mys
tery; there were two subjects about
which he never spoke— his age and his
family background. In a general way he
was thought to be of Irish extraction
and to have come from the Ottawa
neighbourhood.
He was a tall athletic person with
strong rather than handsome features,
a brusque manner, fond of argument
and rather against the Establishment
(Fig. 1). He was a great lover of horses
and animals, a good rider, a member of
the Montreal Hunt and the Montreal
Jockey Clubs. Unlike Dr. Edward A r
chibald, he had no interest in research,
and in later life he told one of his assist
ants, Dr. Mason Couper, that it was his
love of animals that had prevented him
from ever doing any experimental or
surgical research.
Keenan’s great interest at the time
and indeed all through his life was the
army and its veterans. While he had
been a member of the Hospital staff
since 1897, this was interrupted by five
years of war service. In 1899 he enlisted
in the Strathcona Horse as its medical
officer with the rank of Captain, and
after 18 months’ service in South
Africa he returned to Canada with the
Distinguished Service Order. For the
rest of his life, no matter what his ac
tual rank might be, his nickname among
his friends was always “ Cap” Keenan.
Immediately after the outbreak of the

*31 Ramezay Road, Westmount, Montreal 217,
Que.

j

„
L —Graduation photograph as M.D.,
C.M. m 1897 at McGill University (Notman
Collection).

First World War, he joined the Prin
cess Patricia’s Canadian Light Infantry
as its medical officer with the rank of
Major. This regiment had been or
ganized by Hamilton Gault of Montreal
and there were many British reservists
in its ranks. It went overseas before the
First Canadian Division; it was sent to
France in December 1914 where it was
attached to the British army. The regi
ment went through all the heavy fight
ing of the following spring and by the
end of the Second Battle o f Ypres, in
June 1915, casualties had reduced its
strength to five officers and 150 men.
The regiment was then withdrawn from
the forward area for reorganization.
The regimental history gives the fol
lowing note on the value of Dr. Kee
nan’s services: “ Major C. B. Keenan,
the distinguished M.O. of ‘The Origin-
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even 1876. The true date was settled by
his death notice in 1953 when he was
stated to have been in his eighty-seventh
year, making 1867 his date of birth.
This discovery aroused some amuse
ment among the older members of the
Hospital staff because when he resigned
voluntarily in 1935 he was at least five
years beyond the official retirement age
of both the Hospital and the University.
His secrecy had paid off.

Fig. 2.—A snapshot probably taken in France
after the Second Battle of Ypres.

als’ was transferred to an important
hospital at Le Treport where he later
became the C.O.* His loss was keenly
felt for by virtue of his personality and
his soldierly qualities he had been one
of the ‘Master Builders’ of the regi
ment.” 1 (Fig. 2).
He returned to Canada in 1917 be
cause of the acute shortage of surgeons
at the teaching hospitals at McGill Uni
versity and took charge of the military
wards at the Royal Victoria and Grey
Nuns’ Hospitals. He remained in active
contact with the medical care of the
veterans until the second year of World
War II when he finally retired from the
army.
To return to the Keenan biography,
the two mysteries— his age and his fam
ily background— were still unsolved.
Books of reference gave widely varying
dates of birth: 1868, 1870, 1872 and
*No. 2 Canadian General Hospital. He was
Officer-in-Charge of Surgery with the rank
of Lieutenant-Colonel.

His family background and early life
still remained a mystery. Campbell
Keenan had kept very few of his per
sonal records and, in 1964 ,when I was
gathering materials for biographic
sketches of the early members of the
Royal Victoria Hospital staff for the
hospital history, the only things his
family could send me were a short note
about his society memberships and a
tattered group of pages loosely sewn
together in a manila paper cover, bear
ing the title “ Dr. C. B. Keenan’s Ar
ticles in the Medical Times of 1844 on
Liebig’s Theories” . There were also a
number of newspaper clippings refer
ring to a series of lectures that a Dr.
Keenan had delivered in the Town Hall
at Brighton, England, in the same year.
“ Liebig” proved to be Professor Liebig
of Giessen, Germany, who is now re
garded as one of the fathers of organic
chemistry. His mechanistic theories, that
all physiologic processes were chemical
reactions which could be repeated in the
laboratory without any contact with
living matter, had aroused a controver
sy with the “ vitalists” almost as violent
as that which attended the announce
ment of Darwin’s “ Origin of Species”
some 10 years later. The Dr. C. B. Kee
nan of 1844 had set himself up as one
of Liebig’s critics, and his approach to
the question was so like the mental
processes of our own Campbell Keenan
that the two men must have been closely
related. Efforts to establish this rela
tionship led to the discovery of our own
Campbell Keenan’s family history
which goes back in a direct line for five
generations (Fig. 3). As a bonus, we
now have a description of the Bell’s
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Edward K eenan m. E liz a b e th
of Aberdeen, Scotland. Went to Ireland
(3 sons)
James Keenan m. Mary Agnew
(7 sons and 1 daughter)

John m. Nancy McKechnie
(10 children)
To Canada 1828

I

Andrew

James

Cam pbell B ., M.D. m. Ja n e
McMurtry Canada in 1846
(3 sons and 1 daughter)

K ille d in a c tio n
in Spain

Army surgeon,
S p ain and Canada
Died i n tro p ic s

Thomas m . *

David Keenan m. Robina
Smith or Maxwell (3 sons)

Dr. C.B. Keenan
(M o n treal)

David Campbell Keenarvf
* Mrs. Thomas Keenan, the compiler of the Family Tree.

+ Mr. David Cam pbell K eenan, O ttaw a, r e t i r e d fa rm e r. Died May 15, 1971.

Fig. 3.—The Keenan family tree.

Corners District School where his
father was the teacher and at which he
received his own primary education
before going on to the Ottawa Collegiate
Institute for his high school studies.
The results of these inquiries are de
scribed in greater detail in the second
part of this article (pages 292 and 293).
After graduation from the Collegiate
Institute, our Campbell Keenan taught
at a village school, similar to the one at
Bell’s Corners, for five or six years. The
school house is still standing near the
entrance to the Connaught Rifle Ranges
but has been converted to a private
dwelling. He went to McGill in 1893 and
graduated in 1897 with his medical de
gree, and a very distinguished scholastic
record. He was the second-year prize
man in the Preliminary Subjects, he
won the Sutherland Gold Medal in
Chemistry, and was the third man in
the final year, winning the prize in sur
gery—a two-volume edition of “A
Manual of Operative Surgery” by Sir
Frederic Treves.
Following graduation he was ap
pointed to the Royal Victoria Hospital
house staff on Dr. James Bell’s service.
Even at that time Bell had established a
four-year system of postgraduate train
ing consisting of a year in surgical
pathology, two years as intern on the
wards, and a final year as resident with
increasing responsibility as time went
on. Keenan had spent the first year in

surgical pathology and a further 11/2
years on the wards and then, as noted
above, he resigned to join the Strathcona Horse. On his return to Can
ada, he was appointed to the attending
staff as a clinical assistant in surgery.
In an address, which appeared in the
Montreal Medical Journal in 1902,2
Keenan described his experiences in
South Africa under the title “Notes of
a Regimental Medical Officer in a
Mounted Infantry Corps”. His chief at
tention was directed to the ravages due
to enteric (typhoid) fever and he made
little reference to military action. In his
address he mentioned that he had met a
McGill classmate, Dr. Charles A. Pe
ters, who was on the staff of a British
fever hospital in South Africa. The
Strathcona Horse had gone directly
from Canada and had not been given
the new vaccine. On the other hand
Peters had joined up in London, and he
often spoke in later life of having been
inoculated by Sir Almroth Wright, the
inventor of the vaccine, while on the
transport going to Capetown. The stan
dardization and dosage of the vaccine
were still in the experimental stage and
some of the reactions were terrific.
However, Peters never had an attack
of enteric fever during the time he was
in South Africa. Keenan’s interest in
animals also comes out; for example, he
notes the superior qualities of the ori
ginal horses, which had come from
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Western Canada, over those supplied by first to go overseas after the outbreak
the British remount depots. There is of war in 1914 and, after his return in
also an amusing story about his ability 1917, he was so involved in his military
as a mule trader and his success in im duties that he almost disappeared from
proving the quality of the mules in the the hospital scene and it was only after
regimental ambulance service. The the sudden death of Dr. Harry Hill and
Strathcona Horse was unusual in other the approaching retirement of George
ways: lassos were standard equipment Armstrong, in 1922, that he was ap
fo r the rank and file. Finally he deals pointed to the rank of full surgeon with
with the selection of men for army a ward service of his own.
When Sir Henry Gray took over as
service. In his opinion, large well
muscled men had their defects— their Surgeon-in-Chief in September 1923,
attacks of illness were more severe and Dr. A. E. Garrow was seriously ill and
so were their wounds. Men of average died the following November. For years
size and the smaller ones were much Garrow had had the largest surgical
tougher. The highly optimistic were service in the Hospital; Sir Henry took
poorer psychologic risks than the pes charge of his beds in the public wards
simistic; the optimists took disappoint and he did not disturb the other serv
ments badly, the pessimist felt he al ices. When he left the Hospital two
ways knew that things would go wrong years later, Dr. Edward Archibald and
and was a little proud that he had been Dr. Keenan were appointed Senior Sur
right from the beginning. I was in geons and divided the surgical beds be
terested to hear in a recent address on tween them. Drs. F. A. C. Scrimger
the choice of men for service in the Far and F. E. McKenty were their respect
North that Dr. Keenan’s criteria are ive assistants. (Scrimger had won the
still on the modern list of desirable Victoria Cross at the Second Battle of
Ypres, and both he and McKenty would
qualities.
In 1904 he was appointed Assistant later be Surgeon-in-Chief of the Hospi
Surgeon of the Royal Victoria Hospital tal.) Archibald was appointed Surgeonin charge of the outpatient department. in-Chief in 1928 but the equal division
He had ward privileges only when the of the surgical beds was maintained
senior members of the staff were out of until they both retired from the active
town, but this restriction was soon re staff at the end of 1935.
Throughout his active life, Keenan
moved. However, there were very few
private rooms and like many of the remained a general surgeon, a good
junior surgeons of the early 1900’s his diagnostician, conservative in outlook,
private work was done largely at the old and a rapid and skilful operator. He
Homeopathic Hospital on McGill Col knew when “ to go in” and when “ to get
lege Avenue. James Bell, A. E. Garrow out” and, as a result, he had few post
and, later, George Armstrong monopol operative infections and complications.
ized the private wards at the Royal Vic He liked to know what he was doing.
For example, as a railway surgeon he
toria Hospital.
Dr. Keenan married Miss Winifred did a great deal of fracture work and,
Hagar in 1905 and transferred his of when Arbuthnot Lane introduced bone
fices to Mountain Street, at that time plating in the management of fractures,
the Harley Street of Montreal. They he spent some time at the Lane Clinic
were both lovers of horses and animals in England before using the method
and, for some years, were active mem himself. According to one of his old in
bers of the Society for the Prevention terns, the late Dr. A. D. Campbell, his
of Cruelty to Animals. Promotion at the results were excellent.
The didactic lectures of the day were
Hospital came slowly after the un
not
in his field but it was a different
expected death of his old chief, Dr.
matter
in the wards. He was a great
James Bell, in 1911. He was one of the
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reader, well informed, dogmatic and al
His private patients were extremely
ways ready for an argument; all these loyal to him. I well remember my sur
qualities had a strong appeal for his prise in 1914 when I heard that Dr.
students and interns. He was a good C. F. Martin had recommended Keenan
teacher and was really at his best in the to Sir Thomas Shaughnessy as the sur
wards and the outpatient department. gical consultant for one o f his family. In
He was one of those who believed that a doing this he had passed over two of
good history was half the battle in ar the senior surgeons of the Hospital. I
riving at a correct diagnosis. In the ear left the Hospital shortly afterwards and
ly days there were a great many Italian did not hear anything more about the
immigrants in the “ Out Door” . Mrs. operation, but the results must have
F. A. C. Scrimger who still has the gift been very satisfactory indeed. In a pro
of languages (Italian, French and Ger file of Lord Shaugnessy which appeared
man) recalls that when she was a stu in The Gazette (Montreal) on February
dent nurse she would often be sent to 20, 1971, E. A. Collard noted that Dr.
the “ Out Door” to act as an interpreter. David Gurd (the family physician) and
In most cases she would find that it was Drs. C. F. Martin and C. B. Keenan had
an old confused Italian patient of Dr. been called to attend Lord Shaughnessy
Keenan’s who understood no English. during his last illness in December
Despite this, the doctor would take end 1923.3 Dr. Keenan apparently still held
less trouble to get a clear history.
his place as surgical adviser and friend
In spite of his brusque manner, Kee of the family some nine years later.
Keenan was an inveterate cigarette
nan was always popular with the nurs
ing staff. He was a minor hero at the smoker and, when absorbed in anything,
time of his return from the South rarely thought of an ash tray; as a re
African war in 1901. His love of horses sult, the ashes often fell on his clothes.
was well known and the story went Stories came back from No. 2 Canadian
round the Hospital that he and his horse General Hospital at Le Treport that he
had served as the models for the eques had been known to operate with a ciga
trian statuary on the Strathcona Horse rette in his mouth. Fortunately chloro
monument which had just been erected form was the anesthetic o f choice in the
in Montreal. The story later proved to British army and as it was not flam
be apochryphal but was widely accepted mable no harm came of this habit. How
by the nurses. He was always a sup ever, his smoking aroused some concern
porter of the weak against the strong, when he returned to Canada in 1917
especially when the Establishment was where ether and explosive gases were in
concerned. One of the nurses who later common use. It was before the introduc
became the secretary of the Nurses’ tion of surgeons’ masks and he would
Alumnae Association told me about her commence washing up while he was
own experience with Dr. Keenan when, smoking and would start for the oper
as an undergraduate, she was taking ating room with the lighted cigarette
her first turn as instrument nurse at still in his mouth. A nurse was always
one of his operations. The head of the stationed at the door of the theatre to
operating-room staff was a real tyrant make sure that he had remembered to
and kept coming into the room and discard the cigarette. The introduction
pointing out her errors in technique, of surgeons masks shortly afterwards
real or imagined. Finally Dr. Keenan made these precautions unnecessary.
looked up and said, “ Will you please
Dr. Keenan retired from practice in
get out of the room and give the girl 1941 and went to Bic, a village on the
a chance.” The nurse said that she Lower St. Lawrence River about 300
would never forget her feeling of relief miles below Montreal. Here he lived in
and self-confidence which followed Dr. a house thought to have been a Hudson’s
Keenan’s outburst.
Bay trading post which had been in the
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possession of his wife’s family, the
Hagars, for many years. The Hagars
had always been collectors of things of
historic interest and the house was a
veritable museum of old French Cana
dian furniture which they had collected
over many years. Here Dr. Keenan had
his own collection of army weapons—
muskets, rifles and pistols and swords—
o f which he was very proud. He died in
1953, his wife having predeceased him
in 1949. They had no children.
T h e K e e n a n F a m il y T ree (Fig. 3)

As noted earlier, our Campbell Kee
nan had not been greatly interested in
family history and had left little infor
mation about his immediate family ex
cept the tattered packet of pages re
moved from the May to November num
bers of the Medical Times of 1844. The
Medical Times, a well-known London
journal, was published from 1839 to
1887. The full title of the articles was
“ The Truths and Falsehoods of the Lie
big Theories With New Views on Some
Important Points of Organic Chemistry
and Physiology” . The articles had
aroused some interest because the writ
er was asked to give three lectures on
the subject in the Town Hall at Brigh
ton, England, in the following autumn.
C. B. Keenan apparently was a good
speaker because newspaper clippings
pasted on the cover state that the lec
tures were delivered before large and
respectable audiences with a sprinkling
o f medical gentlemen whose interest
was held throughout. A final proof is
that the articles drew a counterblast
from Liebig’s own laboratory in Gies
sen.
One of his articles emphasized the
importance of electricity in the actual
transmission of nervous impulses over
the sensory and motor nerves and sug
gested that this electricity might be
produced by chemical reactions in the
body. However, in Keenan’s opinion
chemical reactions were much too slow
to explain the instantaneous sense of
pleasure on kissing a good-looking
woman. Other more intimate situations
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are described in the article, but there
are marginal notes that these were not
suitable for a mixed audience.
The whole approach to the subject
and the love of argument was so like
our own Dr. Keenan that it became im
portant to identify the author. Was it
his grandfather or an uncle or a distant
relative? In 1964, one of my classmates,
Dr. H. T. Douglas, made a search of
early Ottawa directories and found that
the Keenan family held farm property
in the Bell’s Corners area but that the
school teacher had been David Keenan
and not C. E. Keenan as given by Kee
nan’s nephew. Dr. Douglas suggested
that I write Miss Evelyn M. Taylor, a
director and the Secretary of the Carleton-West Russell Historical Society. I
did and her reply brought a regular
mine of information. She had found
one of the few survivors of the original
Keenan family, Mr. David Campbell
Keenan, a retired farmer, then in his
eighties but “ as bright as a dollar” . He
had allowed her to send me a copy of a
well-worn paper which had been found
in a biscuit jar in his mother’s kitchen
after her death at the age of 90. It was
a “ family tree” of the Keenan family
going back for five generations. It set
tled many of our problems.4
The founder of the Ottawa branch of
the family was Edward Keenan, a Scot
tish Presbyterian from Aberdeen, Scot
land, who had gone to Ireland with his
wife and settled in County Antrim, five
miles from Belfast. This would have
been in the early 1700’s. There were
three sons in the second generation. The
eldest son, James, married Mary
Agnew, an Englishwoman, and they had
seven sons and one daughter. The
daughter married a shipwright, went to
Nova Scotia, and was lost to view. The
second son of the third generation, John
Keenan, married Nancy McKechnie and
they had 10 children; one, an infant,
died on the voyage to Canada, but seven
others were born in the Bytown (Otta
wa) area. The family arrived in 1828
two years after the Rideau canal system
was begun. At that time Bytown was a
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collection of log cabins. Miss Taylor’s
informant, David C. Keenan was a
member of this branch of the family.
The third and fourth sons of this
generation, James and Andrew, were
twins and they had joined the army and
served in the Peninsular War under
Wellington. James was killed in action
in Spain but Andrew was an army sur
geon and later came to Canada. His re
giment was stationed in Montreal but
he appears to have visited the Bytown
area “ before a tree was cut” . He later
was transferred to the tropics where
he died from a snake bite.
Dr. C. B. Keenan was the sixth son of
this generation and was the writer of
the Liebig articles. He married Jane
McMurtry and they had three sons and
one daughter, Annie. The old paper had
a note that his wife was a sickly person
who lay in bed for 17 years after the
birth of her family. The family came to
Canada in 1846 and the doctor practised
at Huntley, a village about five miles
from Bell’s Corners. Annie did not come
to Canada with the family. She was left
in the care of one of the doctor’s London
patients, a very rich French lady with
whom she lived until her death 16 years
later.
David Keenan was their eldest son, a
member of the fourth generation and
the father of our own Campbell Kee
nan, and for some years he was the vil
lage school teacher at Bell’s Corners.
The school house and the teacher are
described in the Ottawa Citizen, Decem
ber 12, 1925, in an article by William
Arnold, one of David Keenan’s old pu
pils.5
The school was a one-room frame
building with about 60 scholars ranging
from 6 to 20 years of age. The older
scholars had never attended school and
were learning to read and write. They
sat on benches facing the wall, the desk
being a sloping shelf along the side of
the room. Heating was provided by a
large wood-burning box stove in the
centre and at the end of the room sat
the “ one and only teacher” . As each
group finished its work, it was called
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to the open space between the stove and
the teacher’s desk “ to be heard their
lessons” , during which they always re
mained standing.
Arnold described David Keenan as a
fine-looking young man of 20 or 25
years, one of the best of the early Carleton County teachers o f his day. Letters
in the archives o f the historical society
note that he was a widely read man and
a good conversationalist. However, the
family thought him “ a dreamer o f
things to come” based on his habit of
calling the school together for the last
class of the week when he would speak
of great inventions to come. Like his
father, electricity was one of his favour
ite subjects and he spoke of the day
when it would be produced in large
power-houses and replace steam in fac
tories and workshops.
David Keenan died in Ottawa in the
early 1920’s and, according to Miss Tay
lor, Keenan Street in western Ottawa
was named in his honour.
None of the men o f the Keenan fam
ily ever showed any interest in making
notes about the family history and it
remained for, as the Scots say, one “ not
of the blood” , in short a wife, to put to
gether the old stories about the Keenan
family. If heredity plays any role in the
lives of later members of a family, our
Campbell Keenan’s career might have
been predicted from his family back
ground. He came from a branch of the
family with definite army and medical
leanings. Two of his grand-uncles had
been in the Napoleonic wars, one o f
them was killed in action in Spain
and the other was an army sur
geon. Edward Keenan of Aberdeen, the
founder o f the family, might very pos
sibly have gone to Ireland as a soldier.
This explains our Keenan’s interest in
the army and the war veterans.
Again both the grandfather and the
grand-uncle were medical men and the
grandfather was the doctor in a nearby
village. He seems to have been one of
his grandson’s heroes because the Lie
big articles were the only family papers
which were saved by our Dr. Keenan.
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on Dr. Keenan’s writings; to
There was little money in the family for information
Brenda Cornell and to Miss Caron of the
and it required six years of saving' as a Mrs.
Medical Records Department for searches of
records; also to Dr. Mason Couper
school teacher to allow him to enter Mc hospital
older members of the staff for personal
Gill where he was a serious and success and
ful student. Like his father, he was a recollections.
294

great reader and fond of teaching. He
has left behind him a reputation as a 1.
brusque but kindly man, a great friend
of the poor, a strong believer in the
medical profession and a dependable 2.
and skilful general surgeon.
The author is indebted to Miss Evelyn M.
Taylor of Ottawa for the discovery of the Kee
nan family tree and the article on the Bell’s
Corners school; to Miss Patrick, Assistant
Reference Librarian, McGill Medical Library,
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REVIEW ARTICLE
TISSUE TYPING AND ORGAN TRANSPLANTATION*
D. P. SINGAL, Ph.D., Hamilton, Ont.
T h e principal obstacle to successful
clinical transplantation of a human or
gan is immunologic rejection. The range
of immunologic response varies from
complete acceptance of the grafts ex
changed between identical twins (iso
grafts) to violent rejection of the grafts
obtained from other species (xeno
grafts) . In clinical homotransplanta
tion, the intensity of the host’s immu
nologic response to an allograft is
determined by the degree of genetic
disparity between donor and recipient.
Immunosuppressive therapy has been
remarkably successful in preventing
immunologic rejection of the kidney
graft. However, the large doses of- im
munosuppressive drugs increase the
risk of complications including bonemarrow suppression, a general reduc
tion of immune responses and the
adverse side effects of high doses of
adrenocorticosteroids. Histocompatibil
ity typing may be used to select op
timally compatible donor-recipient pairs
and to decrease the degree of dif
ferences between the two. Such a
method would significantly increase the
long-term survival of the allograft and
decrease the recipient’s requirements
for immunosuppressive therapy.
H isto c o m pa tibility A n t ig e n s

Two major antigenic systems, the
erythrocyte antigens of the ABO system
and the leukocyte antigens of the HL-A
system, have been recognized as im
portant in determining graft rejection
in humans. The HL-A system is the
most complex immunogenetic system
described in man and its antigens are
determined by genes on a single pair of
chromosomes (autosomes). The HL-A
region on each chromosome is divisible
*From the Department of Pathology, McMaster
University, Hamilton, Ont.

into smaller regions or loci. Two loci
are at present well defined: the first
(LA) and the second (four or seven).1"1
To each of the loci belongs a series of
mutually exclusive alleles, i.e. only one
allele each is present a t the first and
the second loci on a chromosome. Thus
a person has four HL-A alleles (two be
longing to each locus) which together
produce his HL-A phenotype. Thus
there appears to be a close analogy be
tween the human HL-A system and the
H-2 antigen system of the mouse.
Fifteen HL-A antigens have been
given international designations, HLAl, 2, 3, 5, 7, 8, 9, 10, 11, 12, 13, 14, 17,
27 and 28. In addition, several other
antigens are currently recognized in
several laboratories. The first locus in 
cludes the antigenic specificities HLAl, 2, 3, 9, 10, 11, 28 and W29, W30,
W31 and W32. The second locus in
cludes HL-A5, 7, 8, 12, 13, 14, 17, 27
and W5, W10, W15, W16, W17, W21,
W22 and W27, and probably other spe
cificities such as SL* and 407*.
T is s u e T y p in g

There are three main methods of tis
sue (serologic) typing for HL-A anti
gens: leukocyte agglutination, platelet
complement fixation, and lymphocyte
cytotoxicity.
Leukoagglutination test is the sim
plest method serologically. This test
involves agglutination of leukocytes,
particularly granulocytes, by antisera
containing antibodies to leukocyte anti
gens—a phenomenon th a t is influenced
by many variables such as pH, tem pera
ture, and ion concentration of the test
medium. Two main methods used are
the defibrinated blood leukoagglutina
tion test of Dausset, and the ethylene
diamine tetra-acetate (EDTA) leukoag
glutination test of van Loghem. The
leukoagglutination test has poor repro-
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ducibility and often gives a number of
false positive and negative reactions.
However, if carefully performed, this
method is very useful, since some anti
gens (e.g. 5a, 5b, and 9a) can only be
detected by this method.
Platelet complement fixation test was
discovered while studying platelet anti
gens, and microtechniques have recently
been developed in many laboratories.4
Platelet suspensions are incubated with
typing antisera and human complement.
The test is reincubated after adding
sheep red cells sensitized with rabbit
anti-sheep hemolysin. The test is read in
the same way as any routine comple
ment fixation test.
Lymphocyte cytotoxicity test is the
method most commonly employed for
leukocyte grouping. A pure suspension
of lymphocytes is allowed react with a
test panel of antisera in the presence of
complement. If the appropriate anti
gens are present on the lymphocytes,
the antibody combines with the antigen
receptor sites. The antigen-antibody
complex, thus formed, activates the
complement components and kills
the cell. Several recent modifica
tions of the test concern the method of
ymphocyte preparation, source of com
plement used and the manner in which
cell death is determined. The principal
advantage of the cytotoxicity test is its
greater reproducibility. Another advan
tage is that HL-A typing by lymphocyte
toxicity can be carried out on referred
specimens even one to two days after
withdrawal of blood, therefore permit
ting cross-testing of blood by several
laboratories.
Histocompatibility

Considerable evidence indicates that
HL-A antigens are transplantation anti
gens.1' Skin grafts in genetically un
related recipients preimmunized with
white cells from donors were rejected
in an accelerated manner." 8 Amos et al.
and Ceppellini et alP observed that skin
grafts exchanged between HL-A-identical siblings survived significantly

Vol. 15

longer than grafts exchanged between
siblings who shared only one haplotype
and between siblings different for both
haplotypes. Few reports have ap
peared that give information about the
relative strength of different HL-A an
tigens. Dausset et al.,11 in skin-grafting
experiments from siblings to their
fathers, found that incompatibility for
HL-A2 and Dal5 seemed to be as
sociated with a short survival time.
To evaluate the importance of HL-A
antigens in allograft survival, kidney
transplant patients are considered in
three categories, depending upon the
relationship between donor and reci
pient: sibling donors (S :S); parental
donors ( P : C ) ; and unrelated donors
(UR). In the related-donors series (S:S
and P:C), we and others have found a
significant difference in the clinical
outcome of matched and mismatched
transplants.12"20 As another measure of
clinical outcome we investigated the
effect of leukocyte-antigen compatibil
ity on the survival of kidney transplants
by plotting actuarial survival curves. In
the sibling donors there was a marked
difference in survival rate between
matched and mismatched recipients— at
four years 92% of the matched trans
plants and only 43% of the mismatched
transplants had survived.13 Hors et al.20
reported 100% survival for HL-A-identical siblings, a significantly superior
percentage than the survival rate of
haplo-identical transplants (P<0.001).
However, the difference in the survival
rate was not as marked in parental
grafts— 81% of matched and 68% of
mismatched transplants at four years.13
In a recent report17 no difference was
observed in the survival rates of
matched and mismatched P:C trans
plants at three months, six months, and
one year after transplantation. Hors
et al.“ reported a better prognosis for
more compatible P:C grafts, although
it was still not statistically significant.
A difference of opinion exists re
garding the value of tissue typing in
cadaver-donor grafts. Van Rood,12 Bat
chelor and Joysey,21 Morris, Ting
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and Forbes,22 Perkins et al,,23 Kissmeyer-Nielsen et al.,'B and Hors et al.,20
achieved better results when the cadav
er donors were well-matched for HL-A
antigens. Hamburger et al,,24 Starzl
et al.,25 and Mickey et al.,1B however,
found no correlation between HL-A
matching and clinical outcome except
when donor and recipient have identical
HL-A antigens. Harris et a l26 have
criticized Mickey’s data on two princi
pal grounds: first, the data are clinical
ly heterogeneous because they were col
lected from more than 50 centres, each
centre using different drugs to control
rejection; and second, the tissue typing
of cadaver blood samples sent from
distant centres could have been faulty.
These objections could be important,
especially in view of the fact that the
data from individual centres, although
small, show significant correlation be
tween compatibility for HL-A antigens
and the prognosis of the renal allograft.
In a recent report, Terasaki and Mic
key19 reanalyzed their data from 188
cadaver transplants tissue typed and
transplanted between January 1969 and
October 1970. A superior outcome of A
(identical) match over incompatible
matches was evident (P = .006).
C omments

Attention is now being focused on the
role of leukocyte antigens in organ
transplantation. The survival data of
the kidney transplants between HL-Amatched sibling transplants provide
conclusive proof that this is the main
histocompatibility system in man. In
the present state of tissue typing, im
munologic failures can virtually be
eliminated by using HL-A-identical sib
lings. Very low levels of immunosup
pression are adequate for long-term
survival of these HL-A-identical trans
plants. However, a certain degree of
scepticism exists, mainly among sur
geons, concerning the role of this sys
tem in unrelated cadaver donor trans
plants.
Several explanations can be given for
the failure to detect a correlation be

297

tween tissue typing and clinical outcome
in cadaver donor transplants. First,
antigens of the HL-A system are com
plex and heterogenous as evidenced by
stimulation in mixed leukocyte culture
(MLC) tests between HL-A-identical
unrelated individuals. Thus, it is now
evident that in unrelated individuals,
phenotypic identity for HL-A antigens
is not equivalent to genotypic identity.
Also, other genetic systems may exert
a major influence on transplant sur
vival. If this is the case, these systems
must be closely linked with genetic
determinants for HL-A. This conclu
sion of close linkage between other sys
tems and the HL-A system is based on
the highly significant correlation be
tween tissue typing and transplant sur
vival in HL-A-identical siblings. It is
still not clear how much influence cross
reactivity between donor and recipient
antigens may have on the clinical out
come of transplants. Incompatibility for
as yet undetected antigens could also
result in this lack of correlation. In
addition, technical tissue-typing prob
lems are frequent with cadaver donors,
especially when lymphocyte suspensions
are contaminated with granulocytes. In
view of these complexities it is not sur
prising that the full potential of tissue
typing in cadaver transplants is yet to
be realized. There is, however, no doubt
that tissue typing, properly performed,
will play an increasingly important role
in determining allograft survival in the
future.
Present donor-recipient matching
schemes cannot adequately predict the
clinical outcome in transplants from
unrelated donors. Hors et al.10 recently
introduced a donor-recipient matching
scheme which has two advantages over
the earlier protocols. It takes into ac
count the probability of incompatibility
due to serologically undetected antigens
and incompatibility due to the cross
reacting antigens belonging to a series.
For one locus, the maximum number
of detectable antigens in both recipient
and donor is four, and the maximum
number of incompatibilities is two. In
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each case total incompatibility is cal
culated locus by locus. Another histo
compatibility grading system, proposed
by Terasaki and Mickey,19 consists of
the calculation of the probability of
acceptance o f given donor antigens or
haplotype by those of the recipient
based on earlier data experience. Opelz
and Terasaki27 have recently proposed a
new matching scheme which takes into
account the immunologic reactivity in
duced in the recipient by primary ex
posures to pregnancies and transfu
sions. Consequently the entire em
phasis o f histocompatibility testing is
shifting to monitoring the effects of
transfusions in the period before hos
pitalization. Five classes of reactivity
are described based on assays for
humoral cytotoxic antibodies. The un
responsive patients in class I (without
cytotoxins fo r more than one year) had
significantly superior survival to re
sponsive recipients in class V (hyperimmunized patients with cytotoxin
against 5 0 % to 1 0 0 % of random cells).
The suitability of these matching
schemes for selection of optimal donors
remains to be investigated.
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R esum e
L’auteur etablih la valeur du typage des tissus pour les antigenes HL-A dans les homo
transplantations cliniques et base notamment
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son opinion sur une abondante litterature. On
a maintenant une preuve incontestable que
les antigenes HL-A sont en fait des antigenes
de transplantation, qui jouent un role primor
dial dans la survie de l’allogreffe.
Meme si on sait aujourd’hui que les epreuves
d’histocompatibilite sont indispensables a la
survie de i’allogreffe et a l’evolution clinique
du malade, il ne faut pas se dissimuler qu’il
reste encore un long chemin a parcourir dans
ce domaine. Evaluer la force comparative de
chaque antigene HL-A, definir avec plus de
precision les antigenes connus, elucider des
questions sur d’autres antigenes, tant sur les
HL-A que sur d’autres loci, et preeiser leur
relation genetique, mettre au point une methode convenable d’appariement de l’histocompatibilite tissulaire entre donneur et receveur,
sont autant de questions capitales sur lesquelles doivent se pencher les chercheurs.
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INCIDENCE OF DIARRHEA
FOLLOWING ILEAL RESECTION
GEOFFREY N. TSE, M.B., B.S., F.R.C.S.[C],*
W. GORDON BEATTIE, M.D., F.R.C.S.[G], F.A.C.S.t and
W. GRANT THOMPSON, M.D., F.R.C.P.[C],t Ottawa, Ont.

T he ileum is the site of bile-salt absorp
tion.1 Ileal resection or bypass leads to
bile-salt malabsorption, and the result
ing increased concentration of bile salts
in the colon stimulates colonic motil
ity,2' 3 interferes with water and elec
trolyte absorption4 and may cause diar
rhea.5 The purpose of this study is to
estimate the incidence of cholerrheic
diarrhea following ileal resection.
M a t e r ia l s

and

M eth o d s

All charts in the Medical Records De
partment of the Ottawa Civic Hospital,
Ottawa, Ontario, between 1961 and 1969
inclusive were surveyed retrospectively,
and 129 patients were found who had
ileal resection or bypass. These included
patients with hemicolectomy and ileal
conduit but not ileostomy' or colostomy.
In 95 of the 129 patients, data from the
case records, questionnaires to doctors
and patients, and interviews were ade
quate to determine the characteristics
of the bowel habit postoperatively.
For the purpose of this study, diar
rhea is defined as at least two unformed
liquid stools daily or three movements
of any consistency daily. Unless a speci
fic diagnosis of active regional enteritis
or bacterial enterocolitis was made by
the attending physician, the diarrhea
was considered non-specific.
The length of ileum resected was
based on measurements taken at patho
logical examination. The diagnoses for
which the resections were undertaken
are indicated in Table I.
•McLaughlin Travelling Fellow.
fProfessor of Surgery, University of Ottawa;
Chief, Department of Surgery, Ottawa Civic
Hospital, Ottawa, Ont.
±Assistant Professor of Medicine, University
of Ottawa; Gastroenterologist, Ottawa Civic
Hospital.
Requests for reprints to: W. Grant Thompson,
1st Link, Ottawa Civic Hospital, Ottawa,
Ontario, K1Y 4E9.

TABLE 1.— D iagnosis in 95 P atients W ith I leal
R esection

Postoperative non-specific
diarrhea
Diagnosis

No. of
cases

Malignancy
Crohn’s disease
Bowel
strangulation
Ileal conduits
Congenital
anomalies
Traumatic lacerations
Carcinoid
tumours
Radiation necrosis
Miscellaneous

Remission
Persistent within 1 year

42
15

1
9

4
4

13
7

3
1

3
3

6

1

2

1

2
2
6

1
1

1
1

95

16

18

R e su lts

Thirty-four of the 95 patients with
ileal resection had non-specific diarrhea
by the criteria stated above. In 16, this
was persistent and present for at least
one year. The remaining 18 patients
had a spontaneous remission within a
year (Table I).
Diarrhea did not develop in the 25 pa
tients who had less than 10 cm. of ileum
excluded. Nine of 29 patients who had
10 to 20 cm. excluded had postoperative
diarrhea; in only three of these did it
last for more than one year. However,
of the 41 patients in whom segments
greater than 20 cm. were excluded, 25
had diarrhea, and in 13 it was persist
ent and lasted at least one year.
With ileoileal anastomosis, the ileo
cecal valve and a segment of terminal
ileum were preserved. Thirty-seven of
the 95 patients had such an anastomo
sis; 10 had postoperative diarrhea. In
only one of these was the diarrhea per
sistent. On the other hand, 58 patients
had an ileocolic anastomosis and 24 had
diarrhea. In 15 of these patients the
diarrhea persisted for at least one year.
Table I indicates that diarrhea is
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roost likely to develop following opera
tion for Crohn’s disease or strangula
tion, and was unusual following surgery
for malignancy.

Discussion
Non-specific diarrhea was found to
occur in approximately one-third o f 95
patients undergoing ileal resection or
bypass. The most probable mechanism
underlying this diarrhea was stimula
tion of the colon by malabsorbed bile
salts,5' 6 here called “ chollerrheic diar
rhea.” 7
If long segments o f ileum were re
moved diarrhea, particularly the per
sistent type, was more likely. This was
true also if the ileocecal valve was sacri
ficed. This may be because the ileocecal
valve controls the release of chyme into
the colon, or because the short segment
of ileum remaining is sufficient to reab
sorb some bile salts.
The incidence of diarrhea following
ileal resection fo r malignancy may be
low compared with that after Crohn’s
disease or strangulation because less
ileum was removed in these cases.

S ummary
One hundred and twenty-nine pati
ents had ileal resection or bypass at the
Ottawa Civic Hospital between 1961 and
1969. The records of 95 contained suf
ficient data for review, and of these, 34
had non-specific diarrhea. In 16 o f these
patients the diarrhea was persistent
and lasted at least one year. Sacrifice of
the ileocecal valve and resection of
greater than 20 cm. of ileum was atten
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ded by a higher incidence o f postoper
ative diarrhea, particularly o f the per
sistent variety.
We thank Mrs. Nancy McGee and Mrs. Mari
lyn Clark for secretarial assistance. Mr. H. L.
Rossman, a medical student, was responsible
for the initial screening of the hospital charts.
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R £ sum e
Les auteurs ont passe en revue les dossiers
de 129 malades ayant subi une resection d’ileon
a I’Hopital Civique d’Ottawa de 1961 a 1969.
Les dossiers de 95 de ces operes contenaient
assez de renseignements pour tirer des conclu
sions. Parmi eux, 34 avaient presente une diar
rhee non-specifique. Chez 16 de ces 34 malades
cette diarrhee etait persistante et avait dure
au moms une annee. Les auteurs ont remarque
que la resection de la valvule ileo-caecale et
de plus de 20 cm d’ileon se traduisait par une
frequence plus elevee de diarrhee postoperatoire, particulierement de la forme persis
tante.
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CHOLESTYRAMINE TREATMENT OF ILEAL EXCLUSION DIARRHEA
W . GRANT THOMPSON, M.D., F.R.C.P.[C],* G. N. TSE, M.B., B.S., F .R .C .S .[C ]f and
W . G. B E A T TIE , M.D., F.R .C .S.[C ], F.A.C.S..J Ottawa, Ont.
D i a r r h e a occurs in about one-third of
patients with ileal resection and persists
in one-sixth.1 Cholestyramine, a bilesalt-sequestering resin, has been used to
treat hypercholesterolemia and the pru
ritus of obstructive jaundice.2 Hofmann
and Poley3 found that cholestyramine,
16 g. daily, relieved postileal resection
diarrhea. Our study assessed the effi
cacy of low doses of cholestyramine in
controlling persistent diarrhea follow
ing ileal resection.
M a t e r ia l

and

M ethod

Fifteen patients with persistent diar
rhea of at least one year’s duration,
which followed ileal resection one to 16
years earlier, entered the study. The
average length of ileum resected was
56 cm. (Table I). The anastomosis was
in the ascending colon in six patients,
the transverse colon in five, the descen
ding or sigmoid colon in three, and the
ileum in one. The patients’ ages ranged
from 16 to 80 years (average 41 years),
and there were four men and 11 women.
Diarrhea was arbitrarily defined as
at least two unformed liquid stools or
three stools of any consistency each
day. All patients had recognized a de
finite deterioration in their bowel habit
following operation. The average stool
frequency was 5.5/day. In Table I, stool
consistency was graded from 0 to 3 (0
formed, 1 soft, 2 loose and 3 watery).
Fourteen of the 15 patients had watery
stools, while in the fifteenth they were
loose.
Before the study, the patients under
went a careful history and physical
examination to rule out specific causes
of the diarrhea. Each patient kept a
‘ Assistant Professor of Medicine, University
of Ottawa; Gastroenterologist, Ottawa Civic
Hospital, Ottawa, Ont.
fMcLaughlin Travelling Fellow.
'.[Professor of Surgery, University of Ottawa;
Chief, Department of Surgery, Ottawa Civic
Hospital.

diary in which he recorded the frequen
cy and consistency of bowel movements
and the presence of perianal burning,
urgency and gas per rectum. During a
one-week control period, a Schilling
test and three-day stool fat collection
were done.
Because the taste of cholestyramine
cannot be imitated or disguised, the pa
tients were told that they would be
treated with two different drugs. Each
received 6 g. daily of either cholestyra
mine or cornstarch in random fashion.
If constipation developed, the dose was
reduced, and if the drug was only par
tially successful, it was increased. The
patients were seen alternately by two
observers who did not know which drug
was being given. If diarrhea persisted,
the second drug was begun after one
week and continued for four weeks. If
the diarrhea improved on the first
drug, the agent was continued for four
weeks, and then a one-week trial with
the second drug was carried out. During
the last week of treatment with the
drug that was given for four weeks,
stool-fat estimations and Schilling
tests were repeated.
The stool fat was measured by a
modification of the van de Earner meth
od.1 Vitamin B12 absorption was meas
ured by the Schilling test.5 T-testing
was done on paired differences of these
values with each patient acting as his
own control.
R esults

Thirteen patients had a 50% reduc
tion in stool frequency while on choles
tyramine (Table I). One patient (no.
6) did not have a reduction in her
twice-daily bowel movement but noted
a change in consistency from watery to
well formed. Although the last patient
(no. 10) had a reduction in her daily
bowel movements from 10 to five on
cholestyramine, they remained at six
per day when the cornstarch placebo

B ow el
freq u en cy
{p er day)
P a tient
no.

S ex/A ge
{years)

resection
{cm .)

M /3 3

48

2.

F /5 4

67

3.

F /2 5

42

4.

M /3 6

60

5.

M /5 0

95

6.

F /4 2

13

7.

F /1 6

63

8.

M /3 7

21

9.

F /4 5

60

10.

F /2 9

26

11.

F /5 3

—

12.

F /8 0

70

13.

F /4 5

46

14.

F /4 2

125

15.

F /2 8

56

M EAN

56

T r a n s v e rs e
c o lo n
A sce n d in g
c o lo n
A sce n d in g
c o lo n
A sce n d in g
c o lo n
T ra n sv e rse
c o lo n
A sce n d in g
c o lo n
A sce n d in g
c o lo n
D e s ce n d in g
c o lo n
S ig m o id
c o lo n
R ecto
sig m o id
T ra n sv e rse
c o lo n
T ra n sv e rse
c o lo n
T ra n sv e rse
co lo n
Ileu m
A sce n d in g
c o lo n

C ontrol

C holestyram ine

C ontrol

72-hr.
stool weight
(g.)

72-hr.
stool fat
(g.)

Schilling
test
(% )

C holestyram ine

C ontrol

C holestyram ine

C ontrol

C holestyram ine

C ontrol

tyram ine

D a ily
dose
of
cholesty(g.)

6

2

3

0

1397

959

13.8

7.5

4.7

8

4

2

2

1074

1368

14.6

5.1

12.2

16.9

3

4

1

3

0

4291

1044

1.7

4.2

18.5

27.9

4

4 .

2

3

1

505

993

8.4

4.2

6.7

13.8

3

8

3

3

1

1568

1593

7.5

7.5

2.4

3.7

9

2

2

3

0

629

867

2.1

1.7

20.5

19.6

3

4

1

3

0

1523

829

13.0

9.5

5.4

6.2

6

5

2

3

2

2105

1224

4.6

3.6

8.6

11.6

6

6

3

3

0

1097

641

11.9

10.8

2.67

7.3

6

6

5

3

2

1354

2480

2.7

4.2

11.2

18.5

9

6

1

3

0

418

420

10.0

9.5

10.9

12.5

6

10

2

3

1

3371

537

7.6

5.2

1.2

1.8

6

4

2

3

0

1362

618

7.7

7 .5

5.86

13.6

6

8

2

3

0

1829

1643

12.9

4.1

16.4

6

3

1

3

0

936

N /A

3.5

N /A

9 .2 5

13.0

2

5.5

2.2

1087
P > .05

8.5

6 .0
P < .05

8.7

1609

10.8

0.76

12.2
P < .01

6

5.4
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i.

distal
anastom osis

Stool
con sistency
{see text)
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TABLE I. — D ata in 15 Patients W ith Ileal E xclusion D iarrhea
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was substituted. The average dose of
cholestyramine was 5.4 g./day.
Fourteen patients had watery stool
on the placebo, and all noted improve
ment on cholestyramine. In nine of
these the movements became formed.
Patient no. 2 noted no change in the
consistency of her loose stools, but had
a 50% reduction in frequency on the
resin. Patient no. 4 had a reduction in
stool frequency from four to two on
cholestyramine, and his watery move
ments became formed. However, he de
veloped a relapse in his regional ileitis
after 12 days of treatment. Patient no.
10, who had an ileosigmoid anastomosis,
had a poor response, but the other seven
patients with transverse or descending
ileocolostomies did well on cholestyra
mine.
Eight patients complained of exces
sive gas per rectum before treatment.
All reported improvement in this symp
tom on cholestyramine.
All 15 patients complained of peria
nal burning initially. Twelve had com
plete relief and three partial relief. All
of the 11 patients who complained of
urgency or tenesmus were improved by
cholestyramine.
The three-day stool weight (Table I)
was reduced in seven patients, and not
changed by more than 300 g. in five.
Patient no. 4, who had a relapse in his
regional enteritis, and patient no. 10 each
had a greater than 300-g. increase in
stool weight. Figures are not available
for patient no. 15.
Nine of 10 patients who had more
than 45 cm. of ileum resected had over
5 g. of fat in the stool per day, while all
four patients with shorter resections
had less than 5 g. of stool fat per day.
Length of resection is not known in pa
tient no. 11. There was a significant
overall improvement in fat absorption
in 14 patients treated with cholestyra
mine (P c.0 5 ).
Eight of the 10 patients in whom over
45 cm. of ileum was resected had ab
normal Schilling tests (less than 10 %
of the administered activity in the
urine). One of the exceptions (no. 14)
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had 125 cm. resected, but the ileocecal
valve and 4 cm. of terminal ileum re
mained. Of the four patients with less
than 45 cm. resected, three were normal.
Cholestyramine treatment caused a
significant improvement in vitamin B12
absorption in these 15 patients (P<.01).
D iscussion

Bile salts irritate the colon in anim
als6' 7 and interfere with electrolyte ab
sorption in the human colon.8 Cholesty
ramine,® by sequestering bile salts, pre
vents this effect and accounts for the
improvement noted in our patients. This
improvement was achieved with an
average dose of 5.4 g./day— one-third
the dose used by Hofmann and Poley.3
It has been suggested that bile salts
exert their cathartic action on the
proximal colon.3 However, five of our
patients who responded to cholestyra
mine had an ileotransverse colostomy,
and two more had an ileodescending
colostomy. It appears that bile salts
exert their cathartic action on the
transverse and descending as well as
the ascending colon.
Presumably, cholestyramine relieves
the pruritus of obstructive jaundice,
by binding bile salts in the gastrointes
tinal tract.2 Whether this accounts for
the relief of perianal soreness in our
patients, or whether it is due to dec
reased stool water is uncertain. The re
lief of urgency or tenesmus may be ex
plained by the reduction in colon motil
ity resulting from bile-salt sequestra
tion. The subjective improvement in
flatulence is unexplained.
In their patients, Hofmann and Poley
demonstrated that if more than 100 cm.
of ileum had been removed, stool-fat ex
cretion was greater than 20 g./day and
response to cholestyramine unlikely. One
of our patients had 125 cm. of ileum re
sected but still had 4 cm. of terminal
ileum. This may explain why the stool
fat was only 12.9 g./day and why the
patient not only responded to cholesty
ramine but had a normal vitamin B12
absorption as well. However, in our 15
patients we found that if more than 45
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cm. of terminal ileum was removed,
malabsorption of fat and vitamin B12
was common, whereas absorption was
usually normal with lesser resections.
Middleton and Thompson® suggested
that rapid transit time may be respon
sible for the steatorrhea of hyperthy
roidism. The small doses of cholestyra
mine used in our patients, because they
controlled the diarrhea and slowed the
transit time, may have increased the fat
absorption. If this does occur, it could
outweigh the steatorrhea-inducing ef
fect of larger doses of cholestyramine
noted by Hofmann and Poley.3
Spenney and Hirschowitz10 observed
increased vitamin B12 absorption in six
normal subjects and one of three pa
tients with ileal disease when treated
with cholestyramine. They suggested
that the enhancement of vitamin B12 ab
sorption is due to binding of bile salts
which ordinarily interfere. The in
creased vitamin B12 absorption in our
patients may be partially explained by
the slowed gastrointestinal transit time.
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Sum m ary

Fifteen patients with persistent diar
rhea of more than one year’s duration
following ileal resection underwent a
double blind trial, alternating cholesty
ramine and placebo. Thirteen had a
50% reduction in stool frequency and
14 had an improvement in consistency
on an average dose of 5.4 g. of choles
tyramine per day. Urgency, perianal
soreness and flatus also decreased in
most cases. Seven patients whose
anastomosis was beyond the ascending
colon also responded. If more than 45
cm. of terminal ileum was removed, fat
and vitamin B12 malabsorption was
likely. Fat and B12 absorption improved
with this small dose of cholestyramine.
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R esu m e

Chez 15 malades souffrant d’une diarrhee
persistante d’une duree superieure a un an,
apres resection d’une portion d’ileon, les au
teurs ont procede a des essais a double inconnue faisant alterner l’administration de choles
tyramine, et de placebo. Sous l’influence d’un
dose quotidienne moyenne de 5.4 g de choles
tyramine, 13 des malades ont obtenu une
reduction de 50% de la frequence des selles
et 14 une amelioration de la consistance
des selles. Le caractere pressant des evacuations, l’endolorissement de la region peri-anale
et la flatulence ont egalement diminue dans
la majorite des cas ont egalement reagi a ce
traitement. Sept malades dont l’anastomose
etait situee au-dela du colon ascendant. Dans
les cas ou on avait reseque plus de 45 cm
d’ileon terminal, il y avait probability d’une
malabsorption de lipides et de vitamine B 12. La
faible dose de cholestyramine utilisee a ete
suffisante pour ameliorer l’absorption des lipi
des et de la vitamine B12.
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PRIMARY MALIGNANT MELANOMA OF THE ESOPHAGUS:
A CASE REPORT

ROBERT C. MOFFAT, M.D., F.R.C.S.[C],* LANCE B. RICHARD, M.D.f and
J. ERNEST GNASS, M.D..J Trail, B.C.
Malignant melanoma of the esophagus

is a rare and unusual tumour; indeed,
many authorities doubt whether it can
occur as a primary lesion in this par
ticular location. Since the first report
in 1906, 31 instances have been re
ported, including one in a child.1 We re
cently had under our care a 54-year-old
man who died from generalized metastases from a primary malignant me
lanoma of the esophagus. This is only
the second such case report in Canada.
Case R eport

A 54-year-old male Caucasian was admit
ted to the Mater Misericordiae Hospital in
Rossland, British Columbia, on May 24,
1970. His main complaints were lethargy,
anorexia, hiccoughs and a weight loss of
over 20 lbs. during the previous two months.
He admitted to some difficulty in swallow
ing solid foods, but his complaints in this
regard were not pronounced. Fluids pre
sented no difficulties and solid foods usual
ly produced hiccoughs. He denied any
nausea and vomiting, but did complain of
occasional pain in his left posterior chest,
particularly in the left periscapular area.
The patient had been a heavy cigarette
smoker for many years.
This man had a subtotal thyroidectomy
for hyperthyroidism in 1968. At that time
an upper gastrointestinal series, including
the esophagus, was reported as normal. Re
trospective evaluation of these films con
firmed this impression.
In 1968 several hypertrophied lymph
nodes were excised from his left axilla. The
pathology of these nodes has also been
reviewed in retrospect and has confirmed
the original diagnosis of reactive hyper
plasia. At no time had he had any skin
lesions excised.
On physical examination there was evi
dence of considerable weight loss, but no
other pertinent physical findings. The liver
was not palpable and there was no obvious
lymphadenopathy. Rectal and sigmoido*Box 1167, North Bay, Ont.
fC. S. Williams Clinic, Trail, B.C.
JTrail Regional Hospital, Trail, B.C.

Fig. 1.—Radiograph demonstrating the large,
bulky, partially obstructing, filling defect in
the lower one-third of the esophagus.

scopic examinations were negative. His he
moglobin was 14.0 g./lOO ml.; urinalysis
was negative; sedimentation rate was 46
mm. in one hour (Westergren) ; total serum
bilirubin was 0.4 mg./lOO ml.; blood urea
nitrogen was 12 mg./lOO ml.; fasting blood
sugar was 103 mg./lOO ml.; alkaline phos
phatase was 6 Bodansky units; serum glu
tamic oxaloacetic transaminase (SGOT)
was 34 units/ml.; total serum protein was
6.7 g./lOO ml. (albumin 4.4 g./lOO ml., glo
bulin 2.3 g./lOO ml.).
The chest films and the barium enema
examinations were within normal limits.
The upper gastrointestinal series revealed
an irregular, polypoid bulky mass in the
distal one-third of the esophagus. As is
evident in Fig. 1, it manifested itself as a
large partially obstructing filling defect,
which extended throughout most of the
lower one-third of the esophagus. Also evi
dence of extrinsic pressure on the esophagus
suggested nodal enlargement.
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During esophagoscopy, a large tumour
mass was visualized approximately 30 cm.
from the incisors and was biopsied. The
original pathological diagnosis was that of
a heavily infected infiltrating squamous
cell carcinoma, Grade 3. In the specimen,
much of the tissue had been destroyed by
the tumour, hence the correct diagnosis,
melanoma, could not be made on the tissue
submitted. An exploratory laparotomy and
left thoracotomy were performed in the hope
that some type of palliative bypass proce
dure would be feasible. However, the liver
contained many small metastatic nodules
that were easily palpable. None o f these
was larger than 1 cm. and a biopsy o f one
revealed a malignant lesion with only a
small amount of pigment. The lung con
tained multiple, small and dark nodules
which suggested malignant melanoma. Sub
sequent sections revealed pigment which
gave a positive histochemical reaction for
melanin. The esophageal tumour itself had
invaded the left hilum and hence no bypass
procedure seemed feasible. We did a gastro
stomy and closed the incisions.
With a pathological diagnosis of malig
nant melanoma, we questioned him again to
confirm that he had never had any skin
lesions removed and again examined the
various common primary sites for malig
nant melanoma such as the skin, eyes, anus,
rectum and genitalia. We even considered
rare sites such as the leptomeninges, naso
pharynx and bronchi. No other plausible
primary source was identified.
Because of the generalized metastases the
patient’s hospital course was rapidly down
hill. He died on September 25, 1970, four
months from the day of diagnosis.
At autopsy, the esophagus contained a
dark tumour 17 cm. long and up to 6.0 cm.
wide arising from the junction of the lower
and middle one-third (Fig. 2). The tumour
adhered to the esophageal mucosa and had
fungated into the lumen. It did not pene
trate deeply into the esophageal wall and
adhered to only one-third of the circum
ference. The primary was by far the largest
tumour mass. He had numerous metastases
in the lungs, consisting o f nodules which
averaged 2.0 cm. in diameter. There were
metastases in the brain and in the various
other abdominal organs, including liver,
adrenals, stomach, etc. He also had second
ary deposits in the lip and scalp.
Certain workers2'5 have attempted to set
up histologic criteria for the pathological
diagnosis of primary malignant melanoma
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Fig. 2.—The primary site of the malignant
melanoma is in the lower one-third o f the eso
phagus. Note the fungating growth which in
volves only a portion of esophageal circum
ference. Several punctate gastric secondary
lesions can also be seen.

o f the esophagus based on junctional
changes in the epithelium. Demonstrable
changes provide reasonable proof o f the
diagnosis, but the absence of such changes
does not exclude the diagnosis because a
rapidly expanding neoplasm may destroy
evidence of such changes before death or
biopsy. Several slides from our specimen
demonstrated junctional changes.
Microscopically these lesions had a pleo
morphic appearance, namely, large oval
and polygonal “ epithelioid cells” and
smaller slender “ sarcomatoid areas” (Figs.
3 and 4). A special stain for melanin was
positive. Only about 5% o f sections taken
from the esophageal mucosa at some dis
tance from the tumour mass revealed
areas with junctional changes. Although
the submucosa contained numerous mela
nin-containing phagocytes, the pathologist
did not regard these as necessarily related
to the junctional changes because the mel
anin production in the tumour itself would
be sufficient to explain their occurrence.
These junctional changes, which covered
areas up to 1.0 cm. long, were usually
limited to the basal layer. However, a few
foci showed greater activity, as Figs. 3
and 4 show.
D is c u s s io n

M alignant m elanom a o f the eso
phagus is m ost unusual and m any w o rk 
ers deny that such a tum our can arise
fro m this organ as a prim ary lesion.
P iccone et al.5 review ed the literature,
w hich contains ov er 30 published re-
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Fig. 3.—Photomicrograph showing an area with junctional changes. Note that the under
lying submucosa is not infiltrated by tumour tissue (H & E X 35).

Fig. 4.—Nevus cells and junctional changes in the mucosa o f the esophagus some distance
from the primary tumour. Several nevus cells are seen beyond the basal layer, particularly to
the left side of the photomicrograph. When seen in the skin these changes would be interpreted
as a junction nevus (H & E, original magnification X 450).
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ports of malignant melanoma of the eso
phagus in which no other primary site
was evident, and called into question the
pathological criteria for diagnosis in
many of the reports. However, the rari
ty with which malignant melanoma me
tastasizes to the esophagus from other
sources strengthens the possibility that
the lesion arises there. The literature
that we have reviewed contains only two
cases of melanoma metastasizing to the
esophagus.8,7 Burnett and St. John8 re
viewed 22,000 autopsies at the Johns
Hopkins Hospital and, although they
found 25 malignant melanomas at vari
ous sites, they did not find a single me
tastasis or primary in the esophagus.
Also, several authors3,9 have reported
that normal esophageal epithelium does
occasionally contain melanin pigment.
In a study of non-selective esophagi, De
la Pava et al.3 found typical melanoblasts with melanin granules and den
drites in the basal layer of a normal
esophageal epithelium in several of
their specimens. Pomeranz and Garlock10 believe that malignant melanoma
probably originates in the melanoblast
— the dendritic cell.
Recently Loring and Zeppa11 and
Raven and Dawson12 have reviewed the
clinical and pathological features of this
tumour. Patients generally present with
dysphagia, but not always. In the pa
tient described here, dysphagia, a late
symptom, was preceded by significant
weight loss, subscapular pain and hic
coughs. The most common location of
this tumour is the middle and lower onethird of the esophagus, and rapid gen
eralized metastases with a fulminating
downhill course are the usual sequence
of events. Unfortunately, this man’s
lesion was not resectable and, anyway,
the results of resection are still poor.
Su m m a r y

A 54-year-old white man had malig
nant melanoma arising in the esopha
gus. Two clinical points in support of
such a lesion arising from esophageal
epithelium are the relatively large size
of the growth compared with the size
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of the many metastases, and the known
rarity with which malignant melanoma
of any site metastasizes to the eso
phagus. The histologic demonstration of
junctional cells in other areas o f the
esophageal epithelium some distance
from the primary tumour suggests the
tumour originated from this structure.
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R esum e
Un homme de 54 ans, de race blanche, presentait un melanome malin survenant dans
l’oesophage. Deux elements cliniques permettent de confirmer que cette lesion provenait
de l ’epithelium oesophagien: d’une part la
taille relativement considerable de la tumeur,
par comparaison avec la taille des nombreuses
metastases et d autre part, la raretd bien connue avec laquelle un melanome malin siegeant
n’importe ou essaime vers l’oesophage. Enfin,
la decouverte histologique de cellules de jonction en d’autres regions de l’oesophage, a une
certaine distance de la tumeur principale, permet d’affirmer que celle-ci avait bien son
origine dans cette structure anatomique.
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PARENTERAL HYPERALIMENTATION IN MANAGEMENT OF
GASTROINTESTINAL FISTULAS*
GEORGE M. WEISZ, M.D.,f GERALD S. MOSS, M.D., F.A.C.S.J and
FRANK A. FOLK, M.D., F.A.C.S.,§ Chicago, III,, U.S.A.

T he continuous secretion of duodenal
and pancreatic juices with their proteo
lytic enzymes militates against the heal
ing of gastrointestinal fistulas due to
trauma or surgery. The skin surround
ing the stoma of the fistula becomes sev
erely eroded. Water and acid-base im
balance complicates the clinical course,
with the loss of electrolyte-containing
fluids. Protein catabolism debilitates the
patient, lowers his resistance and,
hence, sepsis is a common preterminal
complication.
In the past, several methods of redu
cing duodenal and pancreatic secretion
have been tried: dietetic treatment with
low carbohydrate and protein but high
fat intake; the parasympatholytic effect
of atropine; adrenergic stimulation
using ephedrine sulfate; cholinergic
drugs such as methantheline bromide
and propantheline bromide ;1_3inhibitors
of carbonic anhydrase such as acetazolamide; and ethyl alcohol.1’4>5 Each of
these methods had drawbacks.
Further physiologic studies on the
stimulation of external secretions of the
pancreas suggested that a high serum
glucose level—400 mg./lOO ml. or
higher—might inhibit such secretion.6
It was then found that rapid depres
sion of external pancreatic secretion can
be obtained by glucagon infusion, which
inhibits 90% of the secretion.7
The physiologic basis for the preven
tion and management of pancreatic fis
tulas has been reviewed elsewhere.8
Parenteral hyperalimentation re
presents a significant step forward in
the development of surgical nutrition

‘ From the Trauma Unit, Cook County Hos
pital, Chicago, 111.
fD epartm ent of Surgery, Rambam Hospital,
Aba Khoushy Medical School, Haifa, Israel.
{Associate Professor of Surgery, Abraham
Lincoln School of Medicine, University of Illi
nois, Chicago, 111.
§Associate Professor of Surgery, Loyola School
of Medicine, Chicago, 111.

60 mEq.

44 mEq.

10 ml.

Fig. 1.—Preparation of the hyperalimentation regimen.

and the management of the severely ill
patient.9,10
Thomas and Ross," in 1948, reported
complete closure of a pancreatic fistula
by continuous parenteral feeding of
concentrated dextrose and an amino
acid solution (Amigen). Based on this
report Dudrick et al.1* have applied
parenteral hyperalimentation to the
management of digestive tract fistulas.
The purpose of this paper is to de
scribe two patients with pancreatico
duodenal fistulas successfully treated
with parenteral hyperalimentation.
P r e p a r a t io n a n d A d m in is t r a t io n of
H y p e r a l im e n t a t io n F l u id

The different solutions are mixed in a
sterile vacuumized bottle of 2000-ml.
capacity by the closed method (Fig. 1).
The solution contains 1000 ml. of 5%
Amigen dextrose (Baxter Laboratories)
in addition to 500 ml. of 50% dextrose.
Basic metabolic requirements are cov
ered by the addition of one ampule of
sodium bicarbonate (44 mEq.), 60 mEq.
of potassium chloride and 10 ml. of a
multivitamin solution (complex B, vita
mins A, C, and D). Magnesium is ad
ministered intramuscularly.13 One unit
(1500 c.c.) of this solution yields 1400
calories.
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This hypertonic solution is infused
over an eight- to 12-hour period into
the superior vena cava through an in
dwelling polyvinyl catheter, inserted
through the cephalic or subclavian vein.
The position of the catheter is checked
radiologically. The metabolic state is
checked daily by determinations of se
rum electrolytes, glucose and urea lev
els, and osmolality of serum and urine.
Urine volume and glucose excretion are
checked every four or six hours and,
when necessary, insulin is administered
if glycosuria develops.
Care of the infusion site must be car
ried out aseptically. The catheter should
be sutured to the skin to prevent in-andout movements. Because the nutrient
solution is an excellent medium for bac
terial growth, the infusion set is
changed daily to prevent septicemia.
A t the Trauma Unit, Cook County
Hospital, Chicago, two patients with
pancreaticoduodenal
fistulas
were
treated by parenteral hyperalimentation
to depress pancreatic secretion.
C a s e Re p o r t s

Case 1.— A 21-year-old Negro man was
admitted to the Trauma Unit with an abdo
minal gunshot wound. Exploratory laparo
tomy revealed perforation of the stomach,
head of the pancreas, and the inferior vena
cava. After a difficult hemostasis and re
pair of the inferior vena cava, gastrostomy
and pancreaticojejunostomy (Roux-en-Y)
were performed and the stomach perfora
tion was repaired. Sump drainage was
placed posterior to the unrepaired lacera
tion of the pancreas as well as anteriorly at
the site of the pancreaticojejunostomy. Dur
ing the first five postoperative days the pa
tient was maintained on intravenous fluid
intake only. On the sixth day, temperature
elevation and tachycardia were noticed. The
sump drainage, which had been declining
from an initial amount o f 50 ml./day, sud
denly increased to 150 ml. on the fifth post
operative day and to 500 ml. on the seventh
day. The secretion showed an amylase ac
tivity of 12,000 Somogyi units. Intravenous
hyperalimentation was started with one
unit during an eight-hour period. The pa
tient tolerated the infusion well. No elec
trolyte, acid-base balance or osmolality dis-

P A N C R E A T IC
S E C R E T IO N
m l./ d o y
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Fig. 2.—Treatment of pancreatic fistula in
Case 1.

turbances appeared. The pancreatic secre
tion decreased over the next three days to
50 ml./day, with undetectable amylase ac
tivity (Fig. 2 ). The patient continued well
until the fifteenth postoperative day when
he died of sepsis, bilateral bronchopneu
monia, and severe uncontrollable gastroin
testinal bleeding, in spite of the cessation of
the pancreatic secretion.
Case 2.— A 28-year-old Negro man was
admitted to the Trauma Unit with an ab
dominal gunshot wound. Laparotomy dis
closed a laceration of the transverse colon,
duodenum (second part) and inferior vena
cava. The vein was repaired and the lacera
tion o f the lateral wall at the duodenum
(0.5 cm. in length) was closed. A gastro
stomy, a retrograde decompressive jej uno
stomy and a distal feeding jej unostomy
were performed. The side of the injured
colon was exteriorized. In the postoperative
period he bled from the mesocolon in the
area of the colostomy. The patient also de
veloped sepsis, ascending cholangitis, and a
pulmonary infection. A lateral duodenal fis
tula appeared in the second week. A month
later, after the treatment of all complica
tions, the fistula was still present, eroding
the surrounding skin area. An upper gas
trointestinal roentgenogram showed that
the lumen o f the fistula equalled that o f the
duodenum. The gastrostomy tube had
slipped out. Neither the gastrostomy nor
feeding jejunostomy sites showed signs of
healing. The decompressive jejunostomy
tube was removed because it was ineffect
ive. Two months after injury, 700 to 800 ml.
of duodenal secretion was being collected
daily. The patient had lost approximately
50 lbs. A three-unit hyperalimentation diet
was administered daily for the next 15 days.
The patient gained 24 lbs., started to
walk, became active, and regained his appe
tite. All his skin wounds closed and the
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copious fistulous secretion, containing en This technique, intravenous hyper
zymes and electrolytes, decreased at the rate alimentation, deserves a trial in the
of 100 ml./day. The lateral duodenal fistula management of pancreaticoduodenal fis
continued to secrete 20 to 30 ml./day for tulas. An accurate knowledge of the im
another week and then closed completely. pending metabolic disturbances and an
During this week the patient was eating awareness of the possibility of septice
Vivonex (Eaton Laboratories [Division of mia are imperative in its use. This
The Norwich Pharmacal Company, Ltd.], method can induce early closure of di
Paris, Ont.), a hypertonic diet,14 for the
first three days, and then a regular diet. gestive fistulas, healing of wounds and
Three weeks after hyperalimentation was a positive metabolic balance.
started, a repeat upper gastrointestinal ro
For preventive purposes, the hyper
entgenogram showed a normal duodenal alimentation should be used from the
pattern.
early postoperative days. This should

prevent the development of fistulas and,
the same time, accord the patient the
Many gastrointestinal fistulas have at
benefit
of a high caloric intake in the
been treated by parenteral hyperalimen post-traumatic
or postoperative period.
tation since the method was outlined in
1970.1416
Our two cases, showing successful in
hibition of pancreatic secretion and S ummary
closure of a duodenal fistula, substan This article deals with the pharma
tiate the efficiency of parenteral hyper cologic inhibition of gastrointestinal
alimentation in a patient who can toler secretions and its clinical application.
The development of inhibitors of pan
ate hypertonic glucose infusions.
The first patient, who was in the creatic exocrine secretion is reviewed.
post-traumatic catabolic phase, de The physiologic basis for different die
veloped a pancreatic fistula and re tetic regimens, the effect of cholinergic
ceived significant benefit from the in drugs, adrenergic stimulants, carbonic
hibition of pancreatic excretion, allow anhydrase inhibitors on pancreatic se
ing healing of the peritoneal inflamma cretion are listed. Also mentioned is the
tion; unfortunately, he died later from discovery of the depressant effect of
glucagon and high glucose infusion on
severe bleeding.
In the second patient, a continually the exocrine pancreas, and the clinical
secreting duodenal fistula interfered application of this last finding, i.e. in
with nutrient absorption and wound travenous hyperalimentation as a de
healing. The inhibition of the duodenal pressant of gastrointestinal fistulas.
secretion allowed rapid anabolism and First mentioned by Thomas and Ross in
closure of the wide fistula which, in 1948, such alimentation was scienti
turn, permitted early feeding by mouth. fically applied in the management of
fistulas by Dudrick et al. in 1970.
The patient recovered completely.
The mechanism of inhibitory effect of We used this method in many cases
the hypertonic glucose and Amigen solu of post-traumatic or postoperative fistu
tion is obscure. Whether the inhibition las. The sterile preparation of the hy
of intestinal secretions is achieved by peralimentation regimen is described
the direct effect of the hyperglycemia and graphically illustrated. Two illus
or by the effect of dehydration has not trative cases were chosen for more de
yet been established.12 In these cases the tailed description.
blood sugar level rose no higher than A man with pancreatic fistula had a
180 mg./lOO ml. and there was no decline of daily pancreatic secretion as
osmotic diuresis. For these reasons, a a result of the treatment, and another,
humoral mechanism is probably respon with duodenal and jejunal fistulas, had
sible for the inhibition, rather than de a reversal of his severe catabolic state,
closure of the fistulas, healing of abhydration.
D iscussion
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dominal wounds and weight gain lead
ing to complete recovery.
In conclusion, intravenous hyperali
mentation, besides providing a high cal
oric intake, depresses intestinal and
pancreatic exocrine secretion. This
method of “ immobilization” rests the
gastrointestinal tract and should be
used to manage fistulas and inflam m a
tory processes of the digestive tract and
its annexes.
We wish to thank the staff of the Depart
ment of Medical Publications, The Hospital for
Sick Children, Toronto, for assistance in the
preparation of this article.
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R esum e

Le present article traite de l’inhibition pharmacologique des secretions gastro-intestinales
et de son application clinique.
II passe en revue les inhibiteurs de la secre
tion du pancreas exocrine. On y trouve un apergu de la base physiologique de differents re
gimes dietetiques, de Faction des cholinergiques, des stimulants adrenergiques, des inhibi
teurs de 1’anhydrase carbonique sur la secre
tion pancreatique. On y mentionne egalement
la decouverte de l’effet depresseur du glucagon
et de la perfusion concentree du glucose sur le
pancreas exocrine. Les auteurs rappellent l’indication clinique de cette decouverte, soit l’emploi d’une hyperalimentation intraveineuse
comme depresseur des fistules gastro-intesti
nales. Cite pour la premiere fois par Thomas
en 1948, ce type d’alimentation a ete applique
scientifiquement dans le traitement des fis
tules par Dudrick en 1970.
Les auteurs ont recouru a cette methode
dans de nombreux cas de fistules post-traumatiques ou postoperatoires. Ils decrivent, en
l’illustrant de quelques graphiques, le mode
de preparation sterile de ce regime d’hyperalimentation. La presentation de deux cas typiques permettent de donner plus de details.
Chez un homme souffrant d’une fistule pan
creatique, le debit quotidien diminua et chez
un autre, porteur de fistules duodenale et jejunale, on nota le renversement d’un etat catabolique severe, la fermeture des fistules et des
plaies abdominales et un gain de poids.
En conclusion, 1’hyperalimentation intravei
neuse, outre l’avantage de sa haute valeur
calorique, permet d’inhiber la secretion intestinale et celle du pancreas exocrine. Cette me
thode “ d’immobilisation” met au repos le tractus gastro-intestinal et devrait etre employee
dans le traitement des fistules et des processus
inflammatoires de l’appareil digestif et de ses
annexes.
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EOSINOPHILIC ENTERITIS OF THE ILEUM: A CASE REPORT*
R. SIVASANKAR, M.D., F.R.C.S.[C], 0. G. LANE, M.D.(Lond.),
F.R.C.Path. and 0. K. HJERTAAS, B.A., M.D., F.R.C.S.(Edin.),
Prince Albert, Sask.
E o s i n o p h i l i c infiltration of the gastro
intestinal tract is a rare condition. The
etiology is unknown, the symptoms are
vague, the diagnosis is rarely made be
fore operation and therapy is limited to
relief of symptoms. The following case
report illustrates some of the features
of the condition.
C ase R eport

Mrs. E. A., aged 63 years, was seen in
August 1970 complaining of crampy ab
dominal pain and bouts of diarrhea. She had
lost weight and tired easily. She had had
these symptoms for about one year.
Her previous history included a gastroen
terostomy in 1926, cholecystectomy in 1935,
a partial gastrectomy in 1946 and a hemor
rhoidectomy in 1957. A hysterectomy was
performed in 1967 for cervical dysplasia.
She had received treatment for anemia
which was attributed to her partial gastrec
tomy. In 1962 and 1968 she had been ad
mitted to hospital for crampy abdominal
pain and diarrhea.
On examination she was thin and, aside
from this, abnormal findings were limited
to the abdomen. Several scars from sur
gical operations were present. There was no
tenderness but, on palpation, there was a
vague suggestion of a mass in the right
lower quadrant.
Laboratory data included hemoglobin of
12 g./lOO ml., erythrocyte sedimentation
rate of 10 mm. in one hour (W introbe), and
leukocyte count of 7200./c.mm. A differen
tial count was not obtained at this time.
A barium enema (Fig. 1) was suggestive
of regional ileitis. In the differential diag
nosis we also considered lymphomatous in
filtration of the small bowel and an as
sociated polypoid lesion in the cecum.
A t laparotomy the terminal ileum was
diffusely thickened and edematous. The
cecum itself felt firm and had a feeling of
fullness, which suggested an intraluminal
mass. We did a right hemicolectomy.
‘ From the Departments of Surgery and Patho
logy, Victoria Union Hospital, Prince Albert,
Sask.
Reprint address: Dr. R. Sivasankar, 110 - 8th
Street East, Prince Albert, Sask.

Fig. 1.—Barium enema showing irregular
narrowing of the lumen with coarse distorted
mucosal folds and polypoid filling defects in
volving the distal five to six inches of ileum
and cecum. The ileocecal valve is also enlarged.

Pathology
The specimen consisted of 44.5 cm. of
distal ileum, the cecum and part of the
ascending colon (together 17 cm.) with the
related mesentery attached. The vermiform
appendix was absent. The terminal ileum
and cecum were firm and tubular, and the
serosa was roughened. The mucosa of the
ileum and cecum was edematous and the
terminal 15 cm. of the former was studded
by numerous tiny white nodules (up to ap
proximately 0.1 cm. in diameter). More distally the nodules were slightly larger and at
the ileocecal valve they were about 0.4
cm. to 0.5 cm. in diameter. On the cut
surface, the wall of the terminal ileum and
cecum was thickened and firm, and the
muscularis stood cut on a semitranslucent
greyish background. The lumen was also
narrowed.
The lymph nodes in the attached mesen
tery were firm and pale brown and varied
in size (up to 2 cm. in diameter).
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Fig. 2.—The submucosa is edematous with
dilated lymphatic vessels and cellular exudate
(H & E, original magnification X 100).

Fig. 3.—Detail of the cellular exudate in
which eosinophils are predominant (H & E,
original magnification X 400).

Microscopic Examination (Figs. 2 and 3)

plasia. The follicles had large germinal cen
tres and the sinuses contained some eosino
phils but mostly lymphocytes and plasma cytes. The pathologist concluded that this
represented eosinophilic enteritis with in
volvement of the cecum.
This woman’s postoperative course was
uneventful and when seen three months
later she was well.
In view o f the pathological findings we
decided to look more closely into her past
history, and some interesting features
emerged. In January 1944 she complained
o f epigastric pain and a radiograph made
elsewhere raised the suspicion o f a malig
nant lesion in the duodenum. We were un
able to obtain any information on the out
come of this investigation. However, in
June 1946, she was admitted to hospital
with upper abdominal pain and radiologic
evidence suggestive of a gastric ulcer. A
partial gastrectomy was performed and we
examined sections from the specimen. The
mucosa was normal. The submucosa was
edematous and heavily infiltrated with eosi
nophils and some lymphocytes. The eosino
philic infiltrate extended into the mus-

The walls o f the ileum and, to a lesser ex
tent, the cecum were thickened from edema
and a cellular exudate involving the sub
mucosa, the serosa and the muscularis. The
mucosa was normal. The submucosa and
serosa contained dilated blood and lymph
vessels, and the connective tissues were
eosinophilic and homogeneous. There were
small pools of liquefaciion degeneration.
The cellular exudate was composed of in
numerable eosinophils together with occa
sional histiocytes and lymphocytes. The
eosinophilic infiltrate was most striking in
the serosa and between the tunics of the
muscularis. Perivascular sites were particu
larly involved but there was no arterial
change. Eosinophils were less numerous in
the sufcmucosa but even here they were
abundant. In addition there was follicular
hyperplasia in the submucosal lymphoid tis
sue and some hypertrophy of the muscularis
towards the ileocecal valve. Larvae, ova, or
mature parasites were not identified.
The lymph nodes in the mesentery were
enlarged by both follicular and sinus hyper-
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cularis which was hypertrophied. The serosa
was not involved. The pathologic changes
were, in our view, the same as those present
in the lesion under discussion.
We also ascertained that, on hospital ad
missions in 1962 and 1968, the leukocyte
counts were 6950/c.mm . (17% eosinophils)
and 7850/c.m m . (4 8 % eosinophils) respect
ively. In December 1959, when she had a
hemorrhoidectomy, the leukocyte count was
6300/c.mm . (9 % eosinophils).
In October 1970, almost one month after
the present operation, the count was 5 5 0 0 /
c.mm. (1 3 % eosinophils) and in December
1970 6500/c.mm . (1 0 % eosinophils). In
May 1971, her diarrhea had worsened and
her leukocyte count was 6500/c.mm. with
2 5% eosinophils. She was placed on predni
sone, 5 mg. three times daily, and obtained
marked symptomatic relief. On June 10,
1971, her leukocyte count was 10,600/c.mm.
with no eosinophils.
A trial of cessation of steroid therapy
was followed by a prompt recurrence of
diarrhea and she is now on a maintenance
dose of 7.5 mg. of prednisone daily. When
last seen, one month ago, she was well.

D iscu ssio n

The literature relating to eosinophilic
granuloma of the intestinal tract has
been fully reviewed by Ashby, Appleton
and Dawson.1
The condition is most frequent in the
fifth and sixth decades of life but can
occur in children.2,3 Men are affected
slightly more often than women. No
part o f the alimentary tract from
pharynx to rectum is free from invol
vement.1 Generally, however, the lesions
are in the gastric antrum or the ter
minal ileum and in either site may be
localized or diffuse.1,4 In this particular
patient, both areas were affected but
the interval between lesions giving rise
to symptoms was some 25 years.
The basic pathological lesion is edema
of the wall of the viscus, particularly the
submucosa, with dilatation of lymphatic
and blood vessels and heavy eosinophilic
exudation.1,3 The process may extend
into the muscularis and the serosa and
even be more severe at these sites than
in the submucosa. However, the changes
in the submucosa initiate the sequence of
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events that lead to symptoms. Gastric
outlet obstruction may be caused by in
termittent prolapse of the mucosa which
sometimes becomes polypoid.4' 5 The
pylorus can become hypertrophied and
the pyloric canal narrowed.6 Similar
changes in the ileum lead to partial
small intestinal obstruction and oc
casionally intussusception.2
The etiology of eosinophilic infiltra
tion of the intestinal tract is as elusive
as that of regional enteritis. Some of the
diffuse cases are associated with eosinophilia in the peripheral blood.4,7 This
lesion is sometimes found in patients
who have asthma, food or drug aller
gies.3 Ashby, Appleton and Dawson1
considered the pathologic changes in
both their cases represented an allergic
response to infestation by the North Sea
herring parasite— Eustoma rotundatum. Their opinion was based on the
clinical history of their patients and 13
cases reported by Kuipers, all of whom
had remnants of parasite larvae in their
lesions. However, they conceded that the
parasite does not cause all cases. The
most frequently offered opinion is
that the lesions constitute an allergic response.1’5' 7 Because the whole of the ali
mentary tract is susceptible it is diffi
cult to reconcile such a view with the
favourable response of some cases to
local resection.1,3>4 Perhaps the follow
up in these cases has not been continued
for a long enough period. Our patient
gave no history suggestive of other al
lergy and she did not eat uncooked or
salted herring.
After a careful prolonged study, Leinbach and Rubin8 concluded that eosino
philic gastroenteritis is not a simple
process that can be reversed by re
moving certain food allergens. The re
sponse is temporary and management
on an elimination diet is impractical.
Ureles et al.* have proposed a useful
classification of this condition. The
primary classification is into the dif
fuse and circumscribed forms. The
former is subdivided into the polyen
teric, monoenteric and regional types.
The circumscribed forms are sub-
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divided into regional and polypoid types.
Salient clinical features and histologic
appearances of each type are described
in their paper. Our case appears to have
been o f the regional type in the diffuse
form.
Vanek10 has effectively disposed o f the
view that the lesions are related to eosi
nophilic granuloma of bone or the an
alogous conditions o f Hand-SchullerChristian and Letterer-Siwe diseases.
The characteristic features differen
tiating eosinophilic gastroenteritis from
histologically similar lesions are de
scribed by Samter, Alstott and Kurlanderu and Swarts and Young.12
Diagnosis is rarely made before oper
ation and these patients are usually ex
plored because of symptoms of obstruc
tion, suspicion of malignancy, or, as in
this case, with a tentative diagnosis of
regional ileitis.
The treatment has usually been re
section o f localized lesions causing ob
struction of the gastric outlet or small
bowel. However, it should be strongly
emphasized that, if diagnosis can be
made before operation, steroid therapy
is the treatment of choice, especially for
the diffuse and recurrent forms o f the
disease.1’ M If the pathologist who re
ported on the gastric specimen in 1946
had been aware o f this entity and i f we
had entertained the correct diagnosis,
our patient might have been spared her
last operation.
Sum m ary
A 63-year-old women with a pro
longed history of gastrointestinal com
plaints was found to have eosinophilic
enteritis. The main clinical and pathol
ogical features of the condition are de
scribed. The authors emphasize that if
the diagnosis is made before operation,
steroid therapy is the treatment of
choice except for obstructive lesions or
where a malignant lesion cannot be
ruled out.
The authors wish to thank Mrs. Margaret
Roy for her secretarial assistance.
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Resum e
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traitement par excellence, sauf dans le cas de
lesions occlusives et dans celui ou il n’est pas
possible d’eliminer la possibility d’une lesion
maligne.
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RINGER’S LACTATE INFUSION WITH SEVERE HEPATIC DAMAGE:
EFFECT ON ARTERIAL LACTATE LEVEL*
S. M YR O N GOLDSTEIN, M.D. and LLOYD D. M acLEAN, M.D., F.R .C .S.[C ],
Montreal, Que.

I n the presence of the shock syndrome,
regardless of etiology, an elevated ar
terial lactate has prognostic value.1'6
This elevation is generally attributed to
anaerobic metabolism in hypoxic tissue.
However, Huckabee7 has noted that ar
terial lactate levels are not determined
solely by cellular oxygenation but can
be raised by epinephrine, bicarbonate,
or pyruvate infusions as well as by
hyperventilation. Lowery, Cloutier and
Carey8 showed that Ringer’s lactate was
as useful as saline in the early resuscitative period of hypovolemic shock in
man. Shires et a l demonstrated that
Ringer’s lactate added to shed blood was
superior to shed blood alone in the re
suscitation of shocked dogs.
Lactic acid is metabolized in almost
all organs, but the liver is the primary
site. Schumer, Moss and Nyhus10 have
shown that lactate metabolism is de
pressed after prolonged hypovolemic
shock and have speculated that this is
due to depressed hepatic function. How
ever, Trinkle, Rush and Eiseman11 dem
onstrated that Ringer’s lactate infu
sions are rapidly cleared in dogs after
hypovolemic shock.
The purpose of this experiment was
to determine the ability of dogs to
handle a rapid exogenous, lactate load in
spite of severe hepatic injury.
M ethod

Fourteen adult mongrel dogs were
maintained on a normal kennel diet for
one week before operation. Under light
pentobarbital sodium (Nembutal) anes
thesia the blood supply to the liver was
isolated by the technique described by
Farkouh et al.12 and total inflow stasis
was maintained for 60 minutes in 10
*From the Department of Surgery, Royal Vic
toria Hospital and McGill University, Mont
real, Que.
Supported by a grant from the Medical Re
search Council of Canada.

dogs. The 14 dogs were divided into
three groups.
Control— Group I
Four dogs were kept under anesthesia
for five hours and given an infusion of
1 1. of Ringer’s lactate solution between
the second and third hours.
Control— Group II
Five dogs underwent 60 minutes of
total hepatic inflow stasis and were
given an infusion of 1 1. of 0.9% saline
during the anhepatic period, viz. the
time during which the dog was totally
without hepatic function because no
blood was flowing through the liver.
Experimental— Group III
Five dogs underwent 60 minutes of
inflow stasis and were given an infu
sion of 1 1. of Ringer’s lactate during
the anhepatic period.
At the end of the anhepatic period,
hepatic circulation was restored and
serial determinations of arterial lactate,
pH and pCCL were carried out. The
incision was then closed and the dogs
were returned to the kennel. No other
attempts were made to prolong the
animals’ survival.
R esults (Tables I to III)

Control— Group I
Immediately after a rapid infusion of
1 1. of Ringer’s lactate solution, the
mean arterial lactate rose from
11.5 ± 3.01 to 22.8 ± 6.1 mg.,/100 ml.
However, within 10 minutes, the ar
terial lactate declined towards prein
fusion values, and one hour after in
fusion the arterial lactate level was at
preinfusion values. There were no
significant changes in arterial pH or
pCCL values. All dogs survived 24 hours.
Control— Group II
Although these dogs

received

no
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TABLE I.—T he E ffect of R inger’ s L actate or Saline Infusion on Arterial L actate L evels . In
Groups II and III the T ime “ O” to “ I mmediately F ollowing I nfusion” is the P eriod of T otal
H epatic Inflow Stasis

Arterial lactate
(m g./lO O m l.)
T im e

G ro u p I

0 ......................................................

11.5
22.8
16.7
9 .3
5 .7

Immediately following infusion....................
10 min. after infusion....................................
1 hr. after infusion.........................................
2 hrs. after infusion...................................

±
±
±
±
±

Group I I

3.0
6.1
6.7
2.9
1.7

15.3
28.2
32.0
31.5
27.1

±
±
±
±
±

11.5
13.0
20.6
17
19

G rou p I I I

11.1
38.4
42.52
32.6
2 7.7

±
7.2
db 8.8
±
8.8
± 12.2
± 17.6

TABLE I I — T he E ffect of R inger’ s L actate or Saline I nfusion on Arterial pH L evels. I n G roups
II and III the T ime “ O” to “ I mmediately F ollowing I nfusion” is the P eriod of T otal H epatic
Inflow Stasis

Arterial p H
T im e

0 ...........................................................

Immediately following infusion.....................
10 min. after infusion ...............................
1 hr. after infusion ...................................
2 hrs. after infusion
.......................

G ro u p I

7.32
7.33
7.35
7.36
7.35

±
±
±
±
±

0.06
0.03
0.04
0.06
0.06

Group I I

7.35
7.21
7.21
7.19
7.20

±
±
±
±
±

0.06
0.C6J
0.08
0.10
0.16

G ro u p I I I

7.38
7.26
7.23
7.25
7.22

±
±
±
±
±

0.07
0.06
0.08
0.05
0 14

TABLE III.—T he E ffect of R inger’s L actate or S aline Infusion on A rterial pC 0 2 L evels . I n
Groups II and III the T ime “ 0 ” to “ I mmediately F ollowing I nfusion” is the Period of T otal
H epatic I nflow Stasis

A rteria l p C 0 2 changes
T im e

0

............................................

Immediately following infusion
............
10 min. after infusion .................................
1 hr. after infusion.........................................
2 hrs. after infusion
...........................

G rou p I

37.0
3 6.7
36.7
35.6
35.8

exogenous lactate, arterial lactate rose
from a preinfusion mean of 15.3 ± 11.5
to 32.0 ± 9.2 mg./lOO ml. 10 minutes
after infusion. Over the subsequent
monitoring period the arterial lactate
tended to remain at this point. The
mean arterial pH fell to 7.20 ± 0.16
mg./lOO ml. two hours after infusion,
but again pC 02 remained relatively
stable in each dog. Only one of the dogs
survived 24 hours.
Experimental— Group III

Except for the immediate rise in ar
terial lactate after infusion, the results
in Group III are similar to those in

±
±
±
db
±

5.0
4.4
5.7
4.0
2.17

Group I I

35.0
38.3
33.6
38.3
37.4

±
5.6
±
9.1
±
9.4
db 12.1
± 12.7

G rou p I I I

33.9
34.9
3 4.5
36.3
42.0

db 7.5
±
8.2
± 12.6 f
± 10.1
d= 15.3

Group II. Two hours after infusion the
arterial lactate in Group III was 27.7 ±
11.0 mg./lOO ml. The mean arterial pH
and pC02 values again remained rel
atively stable. None of these dogs sur
vived 24 hours.
It should be noted that one dog in
both Groups II and III developed severe
lacticacidemia, acidosis and terminal
hypercarbia and died during the third
hour after infusion.
D is c u s s io n

Under normal resting conditions the
lactic acid-pyruvic acid ratio is ap
proximately 10:1. Additional lactate
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diffuses rapidly into cells and is con
verted to pyruvic acid by lactic dehy
drogenase (LDH). Most of the pyruvate
is converted to glycogen but about 20%
is oxidized in the Krebs cycle to create
energy as well as carbon dioxide and
water. Bicarbonate is produced from
lactate through Krebs cycle oxidation
and by the action of carbonic anhydrase
on the carbon dioxide and water. The
sodium salt of the lactate is now avail
able to combine with the HCOs to form
sodium bicarbonate.
Ringer’s lactate is a racemic mixture
containing equal amounts of dextroand levo-lactate of which only the levolactate is oxidizable in the Krebs cycle,
the rest being converted to glycogen,
freeing the sodium ion to combine with
h c o 3.13- 14
If arterial lactate levels correlate
with survival, then in the presence of
severe hepatic injury the addition of
exogenous lactate may falsely raise the
arterial lactate level and this might
mislead the physician.
Farkouh et al.n previously demon
strated that 60 minutes of hepatic in
flow produced marked damage to the
liver as determined by serum enzyme
elevation and depression of mitochon
drial respiration.
As can be seen from the results of the
present experiment the dogs in Group I,
the hepatic circulation of which was not
disturbed, easily tolerated a lactate load
that produced only a transient rise in
arterial lactate and no appreciable
change in pH or pCO=.
Control Group II, which demon
strated the effect of 60 minutes of total
hepatic inflow stasis on arterial lactate
levels without an exogenous lactate load,
points to the revascularized liver as a
source o f lactate. Group III received an
additional exogenous load of 2520 mg.
of sodium lactate; these dogs showed no
significant elevation of arterial blood
' lactate over that seen in Group II (no
exogenous lactate).
We know little about the cause of
death of the dogs in Groups II and III
that did not survive 24 hours after 60
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minutes of total hepatic inflow stasis.
In both groups a progressively rising
arterial lactate and a falling pH ap
peared shortly before death. During the
period of observation, one dog in both
Groups II and III developed a progres
sive lactic acid acidosis and hypercarbia. Because there was no difference
in the survival rate between Groups II
and III, we did not attribute these
deaths to the exogenous lactate load
given to Group III.
From this experiment, there is no evi
dence that exogenous lactate will cause
prolonged or progressive elevation of
arterial lactate in dogs who have a
severe disturbance of hepatic function.
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centration en lactate est revenue aux valeurs
Resume
initiales une heure apres l’infusion. Chez les
du groupe II, le lactate arteriel est
Le but de la presente experience est d’eva- chiens
monte
de
15.3 ± 1 1 .5 a 32.0 ± 9.2 mg/100 ml,
luer la possibilite, pour le chien, de supporter dix minutes
apres que la circulation sanguine
une forte charge exogene de lactate, en pre eut ete retablie.
La teneur en lactate est virsence d’une lesion hepatique severe.
tuellement
demeuree
a ce niveau pendant la
Les auteurs ont utilise 14 chiens batards periode de surveillance
subsequente. Sur le
adultes qu’ils ont repartis en trois groupes. Le plan statistique, il n’y avait
pas de difference
groupe I, compose de quatre chiens, a ete notable dans les resultats entre
groupe II et
maintenu sous anesthesie pendant cinq heures. le groupe III: le lactate arterielle dans
ce der
Entre la seconde et la troisieme heure, on leur nier groupe etait de 27.7 ± 11.0 mg/100
ml
a donne en perfusion un litre d’une solution de deux heures apres la perfusion et le retablisseRinger au lactate. Le groupe II, compose de ment de la circulation sanguine dans le foie.
cinq animaux, a ete soumis a une stase hepa Quant au pH et aux titres de pC02, il n ’y avait
tique totale d’une duree de 60 minutes et a guere de differences entre les anim aux du
regu durant cette periode un litre de solution groupe
II et du groupe III.
physiologique saline a 0.9%. Le groupe III,
La
presente
perm et de croire
comprenant cinq chiens, a subi une stase he qu’une _surchargeexperience
rapide de lactate exogene
patique totale pendant la meme periode mais n’entrainera pas d’augmentation
prolongee ou
a regu un litre de lactate de Ringer.
du lactate dans le sang arteriel de
Les auteurs ont mesure la teneur en lactate progressive
chiens souffrant d’une lesion hepatique severe.

MODERN USE OF BLOOD*

R. K. SMILEY, M.D., F.R .C.P.[C],f Ottawa, Ont.

The purpose of this paper is to
examine two aspects of blood use: (1)
the discrepancy that exists between the
views of individuals prominent in blood
banking about how blood should be used,
and the way blood is being used in cur
rent clinical practice; (2) the ultimate
objectives of transfusion services and
the implications these have for clini
cians.
The major discrepancy between au
thoritative views and our clinical prac
tice is illustrated by the statement
“whole blood transfusion should be rel
egated to the limbo of the shotgun prep"Presented at the Annual Meeting of the
Royal College of Physicians and Surgeons of
Canada, Toronto, Ont., January 1972.
fProfessor and Head, Department of Medicine,
University of Ottawa; Head, Department of
Medicine, Ottawa General Hospital; Consul
tant, Hematology Laboratory, Ottawa General
Hospital, Ottawa, Ont.

aration”.' The term “shotgun prepara
tion” has been used to describe expen
sive pharmaceutical products with mul
tiple components which may not contain
sufficient amounts of a desirable com
ponent, but expose the patient to the
toxicity of all components. These prepa
rations are prescribed by physicians
who are unaware of the precise thera
peutic requirements of patients in the
hope that some ingredient they contain
will be beneficial. By drawing an anal
ogy between whole blood and “shot
gun” pharmaceutical preparations,
blood bankers suggest that the prescrip
tion of whole blood is as irrational as the
use of “shotgun” pharmaceutical prep
arations. There is good evidence that
this viewpoint has not been adopted by
clinicians. For example, one of the
major reasons clinicians prescribe whole
blood is to increase the oxygen-carrying
capacity of a patient’s blood. Because
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the administration of concentrated red
cells accomplishes this objective, one
might anticipate that a major portion of
whole blood collected by the Canadian
Red Cross Blood Transfusion Service
would be issued to hospitals in the form
of concentrated red cells. In 1971, how
ever, only 12.4% of whole blood col
lected by the Red Cross was issued as
concentrated red cells.2
In early 1971 the use of blood was in
vestigated in the Department of Med
icine of the Ottawa General Hospital,
Ottawa, Ontario. One-third of patients
who received red cells received them in
the form of packed cells; the other twothirds received whole blood. In both
groups, the indication for transfusion
was to increase oxygen-carrying capac
ity. The reason two-thirds of these pa
tients received whole blood was simple;
our blood bank requisition permitted a
physician to request whole blood or to
specify a blood component. Our staff
was checking the first box, which in
dicated whole blood was required,
rather than requesting concentrated red
cells. An arrangement was made with
the blood bank director that any order
for “ blood” or “ whole blood” for med
ical patients would be filled by issuing
concentrated red cells unless the respon
sible physician indicated to the blood
bank in writing or by personal contact
that he desired whole blood. No resident
or staff physician has made this request
after a year; presumably the policy
adopted has interfered in no way with
the ability of physicians to provide op
timal patient care. This experience sug
gests that physicians administer whole
blood instead of packed red cells to in
crease oxygen-carrying capacity be
cause they are indifferent to the advan
tages (vide infra) of packed red cells,
not from any conviction that whole
blood is superior for this purpose.
The major difference between blood
use in medical compared with surgical
departments is that a greater number
of surgical patients suffer from hypo
volemic shock, in particular hemorrha
gic shock. As I understand current sur

gical opinion, the treatment of this
shock has two principal objectives: to
restore blood volume and to supply oxy
gen-carrying capacity. Of these two ob
jectives, the first is by far the more
important. Clinical3 and experiment
al4 observations in hypovolemic (hem
orrhagic) shock suggest that the com
bination of concentrated red cells with
crystalloids or albumin, in appropriate
volume, is as effective as whole blood in
attaining these objectives. If these ob
servations are correct, the continued
use of whole blood in surgical depart
ments must stem from indifference of
surgeons to the advantages (vide infra)
and feasibility of using packed red cells
rather than whole blood.
During discussions of the use of red
cells and volume agents other than plas
ma to treat hemorrhagic shock, sur
geons usually raise two objections. The
first is phrased in the following way:
“ The most physiologic substance with
which to replace lost blood is whole
blood.” Two of the characteristics of
acid-citrate-dextrose (ACD) bank blood
(Table I) suggest that the whole blood
received by patients is unlikely to be
physiologic. With its acid pH, elevated
potassium and glucose content, bank
blood resembles blood taken from a ke
totic diabetic with renal failure. The
second point raised by surgeons in de
fence of whole blood is that the plasma
provides substances necessary for he
mostasis, e.g. platelets or coagulation
factors. Because of the disproportionate
requirement for red cells and substances
necessary for hemostasis, it is more ef
fective to provide the necessary red cells
plus the necessary component (s) re
quired for hemostasis. For example, we
treat a bleeding patient with Factor
VIII deficiency with concentrated red
cells plus Factor VIII concentrate,
rather than whole blood, because it is
TABLE I.— pH
of

and P otassium C haracteristics
Stored ACD B lood

Fresh
p H ..............
Potassium. .

7.0
3-4 m E q./l.

21 days
6.5
16-17 m Eq./l.
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not possible to achieve hemostatic levels
of Factor VIII with the amount of Fac
tor VIII contained in the whole blood
that will provide the required red cells.
The use of concentrated red cells,
combined with other blood components
and crystalloids, in situations in which
whole blood is now used has a number
of advantages. The acid and potassium
loads administered are less; the inci
dence of serum hepatitis may be reduced
and certain transfusion reactions (ur
ticaria, fever) are less frequent and less
severe. More important than all these
reasons, valuable components of blood
(platelets, albumin, Factors VIII and
IX ) can be salvaged from the plasma,
which is given to patients who do not
require these substances when they re
ceive whole blood. The plasma so sal
vaged should provide an abundant sup
ply of these components to all hospitals
in Canada. For example, surgical col
leagues complain that the supply of
serum albumin would be inadequate to
permit its routine use with concentrated
red cells in hemorrhagic shock. One fac
tor limiting the supply of serum albu
min is the relatively small volume of
plasma available for fractionation when
whole blood is so widely used. This
vicious circle can be broken by the
maximal use of packed red cells.
If packed red cells are used, is there
any clinical situation in which we must
insist these cells be obtained from fresh
ly collected blood? This question arises
because of the effect of blood storage on
hemoglobin function. Fig. 1, from Beutler,° illustrates diagrammatically the
“ shift to the left” that occurs in ACD
blood during the first two weeks of
storage. Hemoglobin in which the oxy
gen dissociation curve has shifted to the
left has an increased affinity for oxy
gen, and therefore releases less oxygen
to the tissues at any given partial pres
sure. The clinical implications of these
findings remain uncertain. Bunn et al.e
state that resynthesis of the phosphorylated intermediates in the red cell
likely begins soon after infusion; the
oxygen dissociation curve is normal in

P O 2 ( m mil g )
Fig. 1.—Schematic representation of the
‘shift to the left” which occurs in stored ACD
blood. (Reproduced by permission from Beutler
E : “Shift to left” or “ shift to right” in regula
tion of erythropoiesis (editorial). B lood 33:
496, 1969.)

some, but not all, patients by 24 hours.7
Further studies are needed to determine
how quickly the defect in oxygen trans
port is corrected in vivo. A reasonable
interim clinical policy would be to use
the red cells most recently collected in
situations which require massive infu
sions of packed red cells.
Increasing knowledge of the composi
tion of blood, coupled with technologic
developments, has made it possible to
formulate the following- ultimate ob
jectives o f blood banking: (1) To sup
ply the patient with blood components
prepared to replace specific needs. (2)
To supply these needs from a stockpile
of blood components which retain their
original properties for months or years
— referred to subsequently as a “ stable
source” .
The blood bank director would like
to be in the position of a pharmacist,
who can fill a specific prescription at
any hour of the day or night from a
stockpile of drugs with known biologic
activity which does not change over
months or years. Progress towards both
objectives is discussed in the following
paragraphs.
Red Cells
Red cells can be supplied as a compo-
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nent of whole blood for the specific pur
pose of increasing the patient’s oxygen
carrying capacity. The maximal “shelf
life” of red cells is 21 days; if they are
not used in this period they are dis
carded. The 21-day limit is an arbitrary
time adopted by blood banks because
70% or more of the red cells in units of
blood collected in ACD and stored under
blood bank conditions for 21 days will
survive normally in vivo. Red cells pre
served in the frozen state most nearly
meet the objective of a “stable source”.
Different methods have been devised to
freeze red cells and reconstitute them as
concentrated red cells after months or
years in storage,8 and the Canadian
Red Cross maintains a bank of frozen
rare bloods at the National Defence
Medical Centre in Ottawa.9 Expense is
the main argument against more gen
eral use of red cells preserved in the
frozen state. Estimated cost of a unit of
concentrated red cells preserved in the
frozen state is 1.5 to two times the cost
of a similar unit of red cells which has
not been frozen and reconstituted.10
20 %

DEMAND
SUPPLY
Fig. 2.-D iagram m atic illustration of blood
supply and demand.

This estimate does not consider the pat
tern of blood supply and demand in
transfusion services, which is illus
trated graphically in Fig. 2. During
periods when blood supply exceeds de
mand, up to 20% of the red cells may
become outdated (i.e. over 21 days) be
fore they are used. If a monetary value
were placed on the unused red cells, and
if it is assumed they would be salvaged
for use through preservation by freez
ing, the cost of a unit of red cells re
constituted from the frozen state might
well become competitive.
Platelets
Platelet concentrates, as a specific
blood component, have become available
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TABLE II.—Specific P lasma C omponents A vail
able F rom a “Stable Source’’

Serum albumin
Gamma globulin (IgG)
Specific hyperimmune gamma globulin
Coagulation proteins: fibrinogen
Factor VIII
“prothrombin complex”

from transfusion services in recent
years. They may be concentrated from
platelet-rich plasma stored at 22° C. for
96 hours" and some progress has been
made towards developing a “stable
source” through freezing. The problems
of platelet preservation have been re
viewed by Gardner.12
Granulocytes
Preparation and infusion of granulo
cytes as a specific blood component is
feasible. Unlike red cells and platelets,
transfusion services cannot provide
granulocytes prepared from routine
donor collections, and much investi
gative work is needed before a “stable
source” can be anticipated. A detailed
review of usefulness, procurement and
preservation of leukocytes has been pub
lished.13
Plasma Fractions
The two ultimate objectives of blood
banking—to supply specific blood com
ponents from a “stable source”—have
been most nearly achieved in the provi
sion of specific plasma-protein frac
tions. Table II lists the types of specific
components available from a “stable
source”.
Plasma
Whole plasma, derived from single
donors, has a limited place in hemosta
tic disorders, i.e. in uncommon condi
tions for which specific components
have not been prepared, and in more
common disorders (e.g. Factor IX de
ficiency) in which administration of
available concentrates has been followed
by a disturbing incidence of hepatitis.
These concentrates should be avoided
except in serious bleeding.
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Army Medical College and A rm y Blood
Supply Depot, 1967, W ashington, Office
of Naval Research (1969) (ORN re
port DR-143)
P errault R, J ackson JR, Martin -V illar
J, et a l: Experience with use of frozen
blood. Can Med Assoc J 96: 1504, 1967
Chaplin H: Personal communication
M urphy S, Gardner FH : E ffect of stor
age temperature on m aintenance of
platelet viability—deleterious effect of
refrigerated storage. N E n gl J M ed
280: 1094, 1969
Gardner FH : Platelet preservation prob
lems. Cryobiology 5: 42, 1968
Greenwalt TJ, P erry S: P rogress in
Hematology, v 6, New York, Grune &
Stratton, 1969, p 164
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S um m ary

Blood bankers urge clinicians to use
specific blood components rather than 9.
whole blood, but extensive use of whole
blood continues.
10.
Blood component therapy has been 11.
used exclusively for one year in the De
partment of Medicine of an active
teaching hospital.
The reason for failure to use blood 12.
component therapy more extensively 13.
appears to be indifference to the feas
ibility and advantages of this practice.
The ultimate aims of blood banking—
R esu m e
provision of specific blood components
from a “stable source” (see text)—have Une profonde divergence existe entre les
concepts des directeurs de Banques de sang
been reviewed. Considerable progress touchant
des transfusions et la
has been made towards these objectives. fa?on dontlesle modalites
sang est en fait utilise en p rati
As a result of recent progress in the que
clinique. Les directeurs en question estiment que la transfusion de sang entier est une
development of specific blood compo pratique
desuete, qui devrait etre remplacee
nents, clinicians should now think in par l’administration
de composants specifiques
du sang. Les cliniciens continuent, eux, a reterms of the patient’s specific needs and courir
sans discrimination, aux classiques
select components to supply these needs transfusions
de sang entier. L’auteur a voulu
rather than attempting to meet all con comprendre pourquoi
les deux tiers des pa
tients hospitalises dans un service medical receivable requirements with whole blood. cevaient
du sang entier pour retablir la capa
R eferences

1.

TJ, P erry S: Progress in
v 6, New York, Grune &
Stratton, 1989, p 148
2. T ieman E E : Personal communication
3. Greenwalt TJ, P erry S : Progress in
Hematology, v 6, New York, Grune &
Stratton, 1969, p 157
4. Moss GS, Proctor HJ, H omer LD, et al:
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city de transport d’oxygene de leur sang. II
a ainsi decouvert que la faute en etait au medecin qui negligeait de specifier une tran s
fusion de culot globulaire. Au cours de l’annee
suivante, seuls des elements figures ont ete
employes dans ce service et aucun medecin n ’a
reclame de sang entier. L’auteur estime que
les services de chirurgie pourraient utiliser
beaucoup moins de sang entier. Si cette p rati
que n’a pas cours, la faute en revient au chirurgien qui ne connait pas la disponibilite des
elements figures et leurs avantages.
Les Banques de sang se sont fixees comme
objectif ultime de garder en stock des elements
figures specifiques qui, du reste, conservent
leurs proprietes originales pendant des mois,
voire des annees. Dans ce domaine, de grands
progres ont ete realises, mais ceux-ci devront
encore etre perfectionnes avant qu’on puisse
atteindre ces objectifs. L’article etudie ces nouvelles acquisitions pour chaque elem ent figure.
En raison des progres deja realises, les clini
ciens devraient desormais chercher a tra ite r
les besoins specifiques de leurs malades, plutot
que de chercher a couvrir un peu a l’aveuglette
tous les besoins imaginables avec du sang en
tier.
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COMPARISON OF MEDROXYPROGESTERONE AND CORTICOSTEROIDS
IN THE TREATMENT OF CANINE RENAL ALLOGRAFTS*
A. S. MACDONALD, M.D., F.R .C .S.[C ], C. F. F A L V E Y , B.Sc. and
C. C. C H AN , M.D., F.R .C .S.[C ], H a lifa x, N.S.
T he
immunosuppressive potency of
medroxyprogesterone acetate (DepoProvera) as measured by suppression
of antibody production and skin allo
graft rejection in rodents1'6 and renal
allograft rejection in dogs5,6 parallels
that of corticosteroids7'10 when either
agent is used alone. The efficacy of
corticosteroids as an adjuvant to azathioprine (Imuran) in the treatment of
both animals and man following organ
transplantation is well established.1118
Several recent reports suggest that me
droxyprogesterone may also have addi
tive effects when used with azathio
prine.5’ 6- 19 The present study in dogs
receiving renal allografts was under
taken to compare medroxyprogesterone
and prednisone, both with respect to
their effects when given continuously
alone or with azathioprine, and their
ability to reverse rejection episodes in
azathioprine-treated animals.
M a t e r ia l s

and

M ethods

Thirty-seven pairs of unrelated mon
grel dogs of both sexes weighing 7 kg. to
25 kg. exchanged kidneys. The grafts
were placed in the pelvis, and end-toend renal-to-iliac arterial and end-toside renal-to-iliac venous anastomoses
and ureteroneocystotomy were per
formed, followed by immediate excision
of the remaining kidney. Therapy be
gan on the day of operation and the
recipients were allocated at random to
one of 10 treatment groups:
Group 1.— Eight dogs received no
drugs.
Group 2.— Seven dogs received me
droxyprogesterone acetate3 35 m g./kg./
day subcutaneously.
*From the Surgical Research Laboratory, Dalhousie University, Halifax, N.S.
Supported by a grant from the Medical Re
search Council of Canada.

Group 3.— Seven dogs received pred
nisone 25 mg./kg./day orally, or methylprednisolone3 25 mg./kg./day intramus
cularly if nauseated or vomiting.
Group -i.— Six dogs received oral
medroxyprogesterone3 35 mg./kg./day.
Group 5.— Eight dogs received aza
thioprine 5 mg./kg./day with the dose
decreased or discontinued if leukopenia
ensued.
Group 6.— Seven dogs were given
azathioprine 5 mg./kg./day adjusting
the dose by the leukocyte response, and
prednisone 1.5 mg./kg./day for one
week, tapering thereafter to 0.5 mg./
kg./day. If rejection developed pred
nisone dosage was increased to 4.0 mg./
kg./day.
Group 7.— Eight dogs were also given
azathioprine as above but, in this group,
prednisone 4.0 mg./kg./day was given
for rejection and gradually tapered and
discontinued if the rejection episode
subsided.
Group 8.— Eight dogs received aza
thioprine 5 mg./kg. as above and also
medroxyprogesterone 35 mg./kg./day
subcutaneously continuously.
Group 9.— In seven dogs medroxypro
gesterone 35 mg./kg./day subcutaneous
ly was added to the azathioprine only
for rejection and was discontinued if
rejection subsided.
Group 10.— Eight dogs received oral
medroxyprogesterone 35 mg./kg./day
continuously in conjunction with the
normal dose of azathioprine. Leuko
penic animals in all groups were given
either ampicillin or tetracycline 250 mg.
twice daily by mouth or intramuscu
larly.
All dogs had thrice-weekly hemato
crits, white cell counts and differentials,
and blood urea nitrogen and glucose de
terminations. An autopsy was per
formed on all dogs that died and their
kidneys were examined histologically.
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TABLE I — R esults in the 10 T reatment G roups

Group treatment

Average
survival
(days)

Survival in days

% survival beyond
Rejected 20 days

30 days

40 days

1 None

6, 7, 7, 7, 8, 10, 13, 21

9.9

8/8

12

0

0

2 Depo-Provera sub
cutaneously

7, 8, 13, 18, 20, 27, 28

17.3

43

0

0

43

0

0

3 Prednisone or methyl- 9, 10, 15, 16, 20, 24, 27
prednisolone

17.3

m
in

4 Provera

7, 9. 13, 14, 15, 24

13.7

6/6

17

0

0

5 Imuran

6, 8, 17, 24, 30, 43, 50. 64

30.2

6/8

63

50

38

6 Imuran + prednisone

10, 15, 32, 39, 57, 62, 65

40.0

4/7

71

71

43

7 Imuran -f prednisone
for rejection

13, 16, 22, 23, 32, 94

33.3

4/6

67

33

17

8 Imuran + DepoProvera

10, 20, 20, 32. 39, 51, 54, 91

39,8

2/8

88

63

38

9 Imuran + DepoProvera for re
jection

11,31,40, 44, 46, 218*, 730*

53.0

3/7

86

86

71

10, 10, 12, 18, 19, 32, 37, 221*
29.7
6/8
38
38
*In computing average survival, long-surviving animals were credited with 100 days only.

12

10 Imuran

Provera

R esults

The results are summarized in Table
I.

Group 1 (controls).— All died of ure
mia secondary to rejection of the
grafted kidney. Survival ranged from
six to 21 days with an average of 9.9
days.
Group 2 (medroxyprogesterone sub
cutaneously only).— All dogs died of re
jection between seven and 28 days, aver
age 17.3 days.
Group 3 (prednisone or methylprednisolone). Rejection resulted in the
death of all dogs between nine and 27
days, average 17.3 days.
Group U (oral medroxyprogesterone
only).— The six dogs died between
seven and 24 days, average 13.7, all of
rejection.
Group 5 (azathioprine only).— Sur
vival averaged 30 days with a range of
six to 64. Two of these dogs died of
bone-marrow suppression and infection
without uremia.
Group 6 (azathioprine and continu
ous prednisone).— Three out of seven

dogs died of bone-marrow suppression
and infection without uremia at 32, 39
and 57 days. The remainder died of re
jection between 10 and 65 days. The
average for the seven was 40 days.
Group 7 (azathioprine and predni
sone for rejection).— Two dogs in this
group were excluded because they
neither rejected the graft nor received
prednisone. One died at 11 days of an
intussusception and the other survived
over a year. The remaining six dogs
lived from 13 to 94 days, two without
uremia, one died of bone-marrow sup
pression and infection at 32 days, and
the other of viral pneumonia at 94 days
when the blood urea nitrogen (BUN)
was 19 m g./100 ml. This dog had two
rejection episodes reversed by predni
sone which had been discontinued 18
days before its death. The average sur
vival in this group was 33.3 days.
Group 8 (azathioprine and continu
ous medroxyprogesterone).— Average
survival was 40 days with a range of
10 to 91. Seven out o f eight dogs sur
vived 20 days or longer and only three
died of uremia. One died at 20 days of
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P OS T - T R A N S P L A N T

Fig. l.-Prolonged survival of a dog treated with azathioprine in which three rejection epi
sodes were reversed by medroxyprogesterone therapy.

renal artery thrombosis and two died still alive (Fig. 1). A severe rejection
of bone-marrow suppression and infec was reversed at three weeks and several
tion. One died of pneumonia with a subsequent rejections (all in the first
chronically elevated BUN of 60 to 80 year) were reversed by treatment with
medroxyprogesterone. A rejection epi
mg./lOO ml.
Group 9 (azathioprine and medroxy sode at 18 months was only partially
progesterone for rejection).— Survival reversed and at 730 days the dog is
ranged from 11 days to over two years. chronically uremic with a BUN of 70 to
If the two long-term survivors are in 90 mg./lOO ml.
Group 10 (azathioprine and oral
cluded as surviving only 100 days each,
medroxyprogesterone).—
One dog lived
the average for this group is 53 days.
Only one dog lived less than 30 days 221 days and died of paralysis second
and only two died of rejection. One died ary to lumber disc extrusion. The others
at 31 days of bone-marrow suppression died between 10 and 37 days. If the
with a BUN of 26 mg./lOO ml., another long-term survivor is credited with 100
at 44 days of bone-marrow suppression, days, the average for this group is 29.7.
infection and moderate uremia, and a One dog died at 18 days of pneumonia
third died of pneumonia at 40 days with and intraperitoneal abscess with a nor
a BUN of 60 mg./lOO ml. One dog died mal BUN. The others all rejected the
at 218 days of a mite infestation, with graft.
Differential leukocyte counts re
a BUN of 36 mg./lOO ml. This dog had
a severe rejection at 50 days which was vealed that medroxyprogesterone- and
reversed by medroxyprogesterone. The prednisone-treated animals developed
most interesting case is a dog that is lymphopenia which was more profound
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2.—Absolute lymphocyte counts in dogs
treated with methylprednisolone (Group 3) and
medroxyprogesterone acetate (Group 2). The
values are the means of the counts in those
surviving to each time period as the numbers
in each group progressively diminished with
time.

and more sustained with medroxypro
gesterone (Fig. 2).
D is c u s s io n

Survival in all the treated groups was
better than in the controls, and the pro
longations were statistically significant
at the 5% level in all but the oral me
droxyprogesterone group. The results
in the untreated, treated with azathioprine only, and azathioprine-continuous
prednisone-treated groups are similar to
those in earlier reports.2025 There was
no statistically significant difference in
average survival times in any of the azathioprine-treated groups except mar
ginally for that group which received
medroxyprogesterone
for
rejection
crises only (P = 0.06). The results do,
however, confirm previous reports5,6> 19
of the efficacy of medroxyprogesterone
combined with azathioprine in the pro
longation of canine renal allograft sur
vival.
In this study, as in an earlier one,19
parenteral medroxyprogesterone ap
pears to be as effective as, or superior
to, prednisone as an adjuvant. Those
animals receiving the combination of
azathioprine and either continuous or
intermittent medroxyprogesterone died
not of rejection but infection, which in
four out of these nine was associated
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with severe leukopenia. Leukopenia was
just as frequent in the other groups
that received azathioprine but infec
tion was a cause of death in the ab
sence of either leukopenia or uremia in
only the medroxyprogesterone-treated
groups. Both prednisone and Depo-Provera administered continuously with
azathioprine from the day of trans
plant seem to be effective in pre
venting rejection during the first 20
days. Both agents are also effective in
reversing rejection episodes if adminis
tered only when rejection has developed,
which occurred in 80% of the dogs with
in the first three weeks (Table I). DepoProvera is also capable of reversing re
jection episodes in long-surviving allo
grafts even as late as 18 months (Fig.
1). However, once rejection became evi
dent in the azathioprine-only treated
group, reversal did not occur, either
spontaneously or in response to in
creased dosage of azathioprine.
In this study the results with medro
xyprogesterone are not as good as those
reported by Turcotte et al.s■6 They dis
continued azathioprine at 60 days and
reduced the Depo-Frovera to two injec
tions per week. Some deaths from infec
tion and leukopenia could perhaps have
been avoided in our longer survivors if
we had done the same.
Unfortunately, medroxyprogesterone
is poorly absorbed from the gastroin
testinal tract, which probably explains
the inferior results in the group treated
with the oral form. Medroxyproges
terone can be detected in the serum of
dogs as long as 90 days after a single
intramuscular injection. Absorption is
not only prolonged but often incomplete
and granuloma formation at the site of
injection was frequent in our dogs al
though ulceration or sinus formation
did not occur. Like corticosteroids,
medroxyprogesterone causes lympho
penia20 which is more profound and
more sustained with the latter drug
(Fig. 1). It is also catabolic27 causing
weight loss in all the dogs receiving it
in this study, and even more so in rab
bits. When combined with prednisone,
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the weight loss in rabbits is catas
trophic (unpublished observations). It
is reported to decrease granuloma for
mation in rats28 and we have found that
it delays wound healing in both rats and
rabbits (Lenco and Macdonald, unpub
lished).
In croton-oil granuloma pouches, its
anti-inflammatory effects appear to be
equal on a weight basis to those of
hydrocortisone28 with less catabolic and
glycogenic activity.27 The drug acts on
the pituitary to suppress ACTH and
gonadotrophic hormone production (but
not thyrotrophic or growth-hormone re
lease). Adrenal atrophy occurs in expe
rimental animals but adrenal response
to ACTH is prompt and vigorous26 and
withdrawal of the drug is not followed
by symptoms of adrenal insufficiency.
Camanni, Massara and Molinatti29 re
ported that medroxyprogesterone ace
tate supported life and reversed symp
toms of adrenal insufficiency in five
adrenalectomized women. It was not ef
fective in two ovariadrenalectomized
women. Despite extensive clinical use
of this agent over the past 10 years,
there are no reports of Cushing’s syn
drome or adrenal insufficiency second
ary to its use in humans even with the
massive doses used in the treatment of
uterine cancer. Medroxyprogesterone
appears to share the beneficial anti
inflammatory effects of the corticoste
roids without many of the deleterious
side effects.
Survival of renal allografts in dogs
is still measured in days5’ 6' 10’ n’ I5'17' sws
rather than in the months and years
that identical agents achieve in human
kidney transplants. With some justifica
tion it is assumed that any agent suc
cessful in the dog is likely to be even
more effective in man. The results of
this study suggest that medroxyproges
terone may be useful in clinical trans
plantation. The drug would be of par
ticular value where pregnancy is con
traindicated in female transplant reci
pients, and the immunosuppressive and
contraceptive properties of this agent
would be combined.
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Sum m ary

Seventy-two dogs receiving renal al
lografts were divided into 10 treatment
groups. The therapy and the average
survival time for each group were as
follows: (1) controls, 9.9 days; (2) pa
renteral medroxyprogesterone acetate
(Depo-Provera), 17.3 days; (3) predni
sone or methylprednisolone (SoluMedrol), 17.3 days; (4) oral medro
xyprogesterone (Provera), 13.7 days;
(5) azathioprine (Imuran), 30.2 days;
(6) azathioprine plus continuous pred
nisone, 40 days; (7) azathioprine plus
prednisone for rejection, 33.3 days; (8)
azathioprine plus continuous parenteral
medroxyprogesterone, 39.8 days; (9)
azathioprine plus parenteral medroxy
progesterone for rejection, 53.0 days;
(10) azathioprine plus continuous oral
medroxyprogesterone, 29.7 days. It is
concluded that medroxyprogesterone
acetate is as effective as prednisone in
prolonging kidney graft survival and
reversing graft rejection. The two ste
roids appear to have a similar mode of
action, but medroxyprogesterone does
not have many of the deleterious side
effects of corticosteroids.
Medroxyprogesterone was supplied as 100mg. oral tablets (Provera) and as 400-mg./c.c.
injectable (Depo-Provera), and methylpredni
solone injectable 40 m g./c.c. and 67.5 mg./c.c.
(Solu-Medrol) through the courtesy of the Up
john Co., Toronto, Ont. and Kalamazoo, Mich.
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Resum &
Nous avons reparti en 10 groupes 72 chiens
chez lesquels on avait pratique des heterogrefies renales. Le traitement et la peniode
moyenne de survie se presentaient comme suit:
(1) temoins— 9.9 jours; (2) acetate de me
droxyprogesterone parenteral (Depo-Provera)
,
(3) prednisone ou methylprednisolone (Solu-Medrol)— 17.3 jours; (4) medro
xyprogesterone orale (Provera)— 13.7 jours(5) azathioprine (Imuran)— 30.2 jours- (6)
azathioprine plus prednisone continue— 40
jours, ( / ) azathioprine plus prednisone pour
le rejet 33.3 jours; (8) azathioprine plus
medroxyprogesterone parenterale continue—
39.8 ours; (9) azathioprine plus medroxypro
gesterone parenterale pour le rejet__53.0
jours; (10) azathioprine plus medroxyproges
terone orale continue— 29.7 jours. Les auteurs
concluent que 1’acetate de medroxyprogesterone
est aussi efficace que la prednisone pour
prolonger la survie du rein greffe et empecher
la reaction de rejet. Les deux stero'ides ont un
mode d action similaire, mais la medroxypro
gesterone n’a pas autant de reactions secondaires defavorables que les corticoi'des.

Vol. 15

BOOK REVIEWS

332

BOOK R E V I E W S
ARTIFICIAL ORGANS AND CARDIO
PULMONARY SUPPORT SYSTEMS.
Edited by Felix T. Rapaport and John
P. Merrill. 186 pp. Illust. Grune & Strat
ton, Inc., New York; Longman Canada
Limited, Toronto, 1971. $17.25.

This monograph comprises the papers
presented at a symposium held at New
York University in September 1971. In the
first paper, Scribner describes his life
plan concept and emerging interrelation
ship between kidney transplantation and
regular dialysis. Based on his extensive
experience, he describes his plans for the
management of end-stage kidney disease
for long-term active survival. Discussions
of the engineering aspects of artificial
kidneys and of biological considerations
complete the chapter. The next chapter,
“ Cardiopulmonary Support Systems” , con
tains reviews of the current status of the
artificial lung and extracorporeal respir
atory support with auxiliary lungs, and
also considers medical as well as engin
eering aspects. Hill presents clinical ex
perience with prolonged extracorporeal
circulation for respiratory insufficiency.
The artificial heart is discussed by DeBakey and by Kolff. Several contributions
are devoted to assisted circulation with
and without auxiliary lung, including the
bloodless method of external pressure ap
plication. One of the main problems in all
systems is thrombosis, which is ably dis
cussed by Salzman. The third chapter,
“Alimentary and Metabolic Life Support
Techniques” , starts with a description of
long-term parenteral alimentary support
by Rhodes, followed by several contribu
tions on the treatment of liver failure. Fi
nally, the questions of artificial skin and of
organ preservation are discussed briefly.
The monograph is an excellent review of
the current state in the U.S.A. of the pro
vision of artificial organs and of related
topics. It is useful for investigators active
in some of the fields covered in the book.
It can also be considered as an introduc
tion to the field of artificial organs for
medical doctors, engineers and others
interested in these developments. It should
be read by medical students, interns and
residents who require some knowledge of
artificial organs and the implications of
their use, subjects that tend to be in
adequately covered in their textbooks.
W . ZlNGG

The Hospital for Sick Children,
Toronto, Ont.

DIE FETTEMBOLIE. Gyorgy Szabo 284
pp. Illust. Akademiai Kiado, Budapest,
1971. $10.00.

This extensive monograph, written by a
staff surgeon of the Central Institute for
Traumatology in Budapest, discusses fat
embolism in all its aspects. In a series of
logically organized chapters he analyzes
in fine detail the various problems
presented by the condition. His conclu
sions are based on his extensive personal
experience (200 cases). The book is com
pleted by a series of references in the
medical literature dating from 1669 to the
present.
The discussion in the final chapter of
the causes of death in fatal cases of fat
embolism is of great medicolegal impor
tance and deserves the careful attention of
all doctors working in general and ortho
pedic surgery.
L. G. F a r k a s

The Hospital for Sick Children,
Toronto, Ont.

GASTROESOPHAGEAL REFLUX AND
HIATAL HERNIA. Edited by David B.
Skinner, Ronald H. R. Belsey, Thomas
R. Hendrix and George D. Zuidema. 208
pp. Illust. Little, Brown and Company
(Inc.), Boston; J. B. Lippincott Com
pany of Canada Ltd., Toronto, 1972.
$13.50.

The authors of this text are experienced
and well known in the field of esophageal
studies. They have combined their talents
to produce a book which clearly is the best
available text on the subject of hiatal
hernias. They have extensively reviewed
the literature and have described well
the anatomy, physiology and pathology
of hiatal hernias. Using this basic knowl
edge they have outlined their approach to
the investigation and management of eso
phageal disease.
The authors describe the various ap
proaches to surgical management with
emphasis on the procedures that they have
been responsible for pioneering. Their
own extensive experience is reviewed to
illustrate the problem areas of esophageal
surgery.
The discussion of alternative surgical
management, particularly in the area of
(Continued on Adv. p. 30)
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peptic stricture, is brief, and these
techniques are too readily dismissed as
being of little value.
The book is easy to read, well illustrated
and contains most of the references rele
vant to the work described. Anyone in
terested in the field of esophageal surgery
will find the book provocative and prof
itable.
R. D. H enderson

Toronto General Hospital,
Toronto, Ont.

M ODERN TRENDS IN ORTHOPAEDICS
— 6. Edited by A. Graham Apley. 273 pp.
Illust. Butterworth & Co. (Publishers)
Ltd., London; Butterworth & Co. (Can
ada) Ltd., Toronto, 1972. $28.90.

This volume makes no claim to be ex
haustive or comprehensive but devotes at
tention to a number of topics that are of
current interest to orthopedic surgeons
and therefore reflects present-day prac
tice. It should be of particular value to
residents in training and should be placed
in the library of every teaching orthopedic
department. From time to time throughout
the book an unusual slant on a common
topic is encountered; for example, the ref
erence to manipulation in the chapter on
epidurography and the discussion of the
“ ideal hip” in the chapter on total hip
replacement. In this way some excitement
is provided. The book is clearly written
and the illustrations, which are numerous,
are all of excellent quality.
W . H . K ir k a l d y -W illis

University Hospital,
University of Saskatchewan,
Saskatoon, Sask.

ORTHOPAEDIC SURGERY IN SPASTIC
IT Y. Harold M. Frost. Orthopaedic
Lectures, Volume I. 216 pp. Illust. Char
les C Thomas, Publisher, Springfield,
111.; McGraw-Hill Company of Canada,
Toronto, 1972. $15.20.

The natural history of orthopedic surgery
in spastic disorders is all too often a
relentless progression from proselytizing
enthusiasm in the young staff surgeon to
cynical skepticism in his more senior
colleagues. Dr. Frost has obviously
laboured long and conscientiously in the
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field but has resolved to eschew negativ
ism in favour of struggling to separate the
wheat from the chaff and, what is more
important, to attempt a logical decision
as to whether to thresh at all.
The first section of the monograph at
tempts to explain why the locomotor sys
tem of the spastic is unique. It is em
phasized that the laboriously acquired
knowledge and techniques applicable to
the handling of post-poliomyelitic motor
defects have relatively little to offer
in the problems of the spastic. Dr. Frost’s
concepts are based on practical experience
and personally evolved rules that work
for him—and as such are untested by
neuroanatomical or neuropathologic in
vestigation.
The author then discusses specific com
mon problems and his own techniques for
management. Of particular value is the
endeavour to explain why the success of
one technique could be anticipated; op
tional techniques are carefully assessed
rather than curtly discarded.
While of undeniable interest and value
to orthopedic surgeons at all levels of ex
perience, this book does not make for easy
reading. It does, none the less, contain a
great deal of information (often in what
are almost side comments) on the value
of non-surgical measures, including
bracing. Particularly, there is an under
lying philosophy of encouragement for all
those involved in the overall management
of the still baffling and perplexing peri
pheral manifestations of central neurol
ogic disease.
In summary this book is a useful contri
bution to the literature concerning ortho
pedic surgery in cerebral palsy.
W. J. S. Melvin

Scarborough General Hospital,
Scarborough, Ont.

ORTHOPAEDICS IN IN F A N C Y A N D
CHILDHOOD. G. C. Lloyd-Roberts.
Postgraduate Paediatrics Series. General
Editor: John Apley. 337 pp. M u st.
Butterworth & Co. (Canada) Ltd., To
ronto; Butterworth & Co. (Publishers)
Ltd., London, 1971. $26.00.

Although orthopedic surgeons have accu
mulated a vast amount of clinical experi
ence in the problems of pediatric patients,
relatively few texts in children’s ortho
pedics are available. The deficiency is suc
cessfully alleviated by this comprehensive
text.
(Continued on Adv. p. 39)
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T he volum e p re s e n ts th e clin ic a l ex
perien ces and p h ilo so p h ies of its a u th o r,
an em in en t B ritis h o rth o p ed ic su rg e o n on
th e s ta f f of th e H o sp ita l fo r Sick C h ild ren ,
G re a t O rm ond S tre e t, London. H e d eals
w ith p a rtic u la r p roblem s acco rd in g to th e
diseases resp o n sib le an d th e a n a to m ic a l
a re a s involved.
T he te x t w ould have b e n e fite d fro m
c o n trib u tio n s by o th e r em in en t o rth o 
pedic su rg eo n s w ith e x p ertise in th e s u b 
je c ts included in th e c h a p te rs on m e ta 
bolic diseases, m iscellan eo u s co n d itio n s,
th e sh o u ld er an d elbow, and th e fo re a rm
an d h an d . C h a p te rs th a t deserve o u ts ta n d 
in g p ra ise a re th o se devoted to in fe c tio n s
o f bones and jo in ts, d iso rd e rs o f th e cen 
tr a l nervous system , th e spine a n d tru n k ,
th e hip and th ig h , th e foot, and th e sectio n
e n title d “G eneral T o p ics” .
T he book w as m ean t to be a g u id e fo r
p e d ia tric ia n s an d a u se fu l m a n u a l fo r
o rth o p ed ic su rg e o n s and succeeds s u p e rb 
ly. I t is recom m ended fo r g e n e ra l p r a c ti
tio n e rs, m edical s tu d e n ts, and in te rn s and
re sid e n ts in b o th p e d ia tric s a n d o rth o 
pedic su rg ery .
The illu stra tio n s , a lth o u g h re la tiv e ly
few in num ber, a re o f ex cellen t q u a lity .

The b ib lio g rap h y w ill, in m o st in sta n c e s,
be o f g re a t b en efit to th o se in te re s te d in
f u r th e r re a d in g a b o u t an y sp e c ific s u b 
ject.
T h is te x t can be r e a d w ith e n jo y m e n t as
w ell as p ro fit and w ill be of th e g r e a te s t
serv ice to a ll w ith a n in te re s t in o rth o 
pedic problem s in c h ild re n .
R.

A .

S il v

e r

U.S. P u b lic H ealth S erv ice H o sp ital,
S e a ttle, W ash.

SURGICAL DISORDERS OF THE PERI
PHERAL NERVES. Herbert Seddon.
332 pp. Illust. Churchill Livingstone,
Edinburgh and London; Longman Can
ada Limited, Toronto, 1972. $29.00.
S ir H e rb e rt Seddon w a s one o f th e m em 
b ers o f th e P e rip h e ra l N erve C om m ittee
o f th e M edical R e se a rc h C ouncil o f E n 
g la n d resp o n sib le f o r policies to im prove
th e m an agem ent o f n e rv e in ju rie s d u rin g
W orld W ar II. It is a d elig h t, th e re fo re ,
to have availab le th e ex ten siv e e x p e rie n c e
of th is su rgeon in a fo rm f o r s tu d y by
th o se of us also e n g a g e d in th is p ro b lem ,
and fo r th e young m en of th e f u tu r e . A
b rie f exposition o f o u r p re se n t know ledge
(Continued on Adv. p. 41)
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re g a rd in g g ro ss an d u ltr a s tr u c tu r e o f th e
n e rv e s is follow ed by a s ta te m e n t of
p re s e n t th in k in g on th e pro b lem s of
d e g e n e ra tio n an d re g e n e ra tio n . T h e a u 
th o r o u tlin es th e g e n e ra l c lin ic a l ex
a m in a tio n in detail. H e d escrib es th e
p ro g re ss d u rin g reco v ery and th e use of
e le c tric a l in v estig atio n in d ia g n o sis and
pro g n o sis. The m ech an ism s of in ju r y a re
d iscu ssed , w ith ta b le s sh o w in g th e re la tiv e
involvem ents of in d iv id u a l n erv es as w ell
as th e - likely dam age to o th e r tis s u e s in
th e ir v icin ity . The p a in fu l c o n d itio n s a s 
so ciated w ith p e rip h e ra l nerve in ju rie s
a re w ell d iscussed, p a r tic u la rly th e d is
tin c tio n betw een tru e c a u sa lg ia a n d th e
o th e r m ore common p a in fu l sy n d ro m es.
A fte r th e d escrip tio n o f g e n e ra l p roblem s,
th e n erv es a re co n sid ered in d iv id u a lly in
co n sid erab le detail. T he sectio n on t r e a t 
m en t deals n o t only w ith o p erativ e p ro 
c e d u re s b u t also w ith p re o p e ra tiv e m a n 
ag em en t and th e tr e a tm e n t o f re s id u a l
fu n c tio n a l d isa b ilitie s. T he a u th o r ’s r e 
su lts receive d etailed a n a ly sis a n d th e
book is com pleted w ith a c o n sid e ra b le lis t
o f re fe re n ce s.
T h is book should be in th e lib r a r y of
th e su rg e o n d ealin g w ith p e rip h e ra l n erv e

d iso rd e rs an d sh o u ld fo rm p a r t o f th e r e 
q u ired re a d in g fo r re s id e n ts in tr a in in g in
n e u ro su rg e ry , o rth o p e d ic s u rg e ry an d
p la stic su rg ery .
K.

W .

E.

P

a in e

U n iv e rsity H ospital,
U n iv e rsity of S ask atch ew an ,
S askatoon, Sask.

TRANSPLANTATION REVIEWS. 7. Im
munological Surveillance Against Neo
plasia. Edited by Goran Moller. 178 pp.
Illust. Munksgaard, Copenhagen, 1971.
Dan. Kr. 92,00. $13.25 (approx.). Paperbound.
“Im m unological
S u rv e illa n c e
in
N eo
p la s ia ”, n u m ber 7 in a se rie s e n title d
“T ra n s p la n ta tio n
R ev iew s”, is
in tr o 
duced a p p ro p ria te ly by S ir M a c F a rla n e
B u rn et. I t is now g e n e ra lly a g re e d th a t
m ost, b u t n o t n e c e s s a rily all, m a lig n a n t
cells have a n tig e n ic q u a litie s d is tin c t
fro m th o se of th e cell ty p e fro m w h ich
th e y are derived. F u rth e rm o re , su c h a n ti
genic d iffe re n c es can, u n d e r a p p ro p ria te
co n d itio n s, be reco g n ized as fo re ig n an d
(Continued on Adv. p. 43)
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THE CANADIAN JOURNAL OF SURGERY
All communications concerning this journal
should be marked “The Canadian Journal of
Surgery” and addressed to the Editor, P.O.
Box 8650, Ottawa, Ontario K1G 0G8.
The Journal is published bi-monthly. Sub
scription is $15 per year ($7.50 per year for
trainees in surgery) and starts with the Janu
ary issue of each year. Single copies are $2.50
each, payable in advance.

INSTRUCTIONS TO CONTRIBUTORS
Manuscripts
Manuscripts in duplicate of original articles,
case reports, and other contributions should
be forwarded with a covering letter re
questing consideration for publication in
The Canadian Journal of Surgery. Accept
ance is subject to the understanding that
they are submitted solely to this Journal,
and will not be reprinted without the con
sent of the author and the publishers. Ac
ceptance or rejection of contributors will be
determined by the Editorial Board. As
space is available, a limited number of case
reports will be published. Articles should
be typed on one side only of unruled paper,
double-spaced, and with wide margins. The
author should always retain a carbon copy
of material submitted. Every article should
contain a summary of the contents. The
Concise Oxford Dictionary will be followed
for spelling. Dorland’s Illustrated Medical
Dictionary will be followed for scientific
terminology. The Editorial Board reserves
the right to make the usual editorial changes
in manuscripts, including such changes as
are necessary to ensure correctness of gram
mar and spelling, clarification of obscurities
or conformity with the style of The Cana
dian Journal of Surgery. In no case will
major changes be made without prior con
sultation with the author. Authors will
receive galley proofs of articles before pub
lication, and are asked to confine altera
tions of such proofs to a minimum.
Reprints
Reprints may be ordered on a form which
will be supplied with galley proofs. It is
important to order these before publication
of the article, otherwise an extra charge
for additional type-setting will be made.

References
References should be referred to by numer
als in the text. They should include in
order: the author’s name and initials in capi
tals, title of the article, abbreviated journal
name, volume number, page number and
year. The abbreviations of journal names
should be those used in Index Medicus.
References to books should include in order:
author’s name and initials, title of book,
number of edition (e.g. second ed.), city
of publication, title of publishing house,
year of publication, page number if a
specific reference. For examples, see this
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white
illustrations will be reproduced free with
the articles. Colour work can be published
only at the author’s expense. Photographs
should be glossy prints, unmounted and
untrimmed, preferably not larger than 8"
x 6". Prints of radiographs are required
and not the originals. The magnification of
photomicrographs must always be given.
Photographs must not be written on or
typed on. An identifying legend may be
attached to the back. Patients must not be
recognizable in illustrations, unless the
written consent of the subject for publica
tion has been obtained. Graphs and dia
grams should be drawn in India ink on
suitable white paper. Lettering should be
sufficiently large that after reduction to
fit the size of the Journal page it can still
be read. Legends to all illustrations should
be typed separately from the text and sub
mitted on a separate sheet of paper. Illustra
tions should not be rolled or folded.
Language
It should be clearly understood that con
tributors are at full liberty to submit articles
in either English or French, as they please.
Acceptance will be quite independent of
the language of submission. If the contri
butor wishes, he may submit an informative
summary of not more than 300 words in
the language other than that in which he has
submitted the article. For example, an ar
ticle in English must carry an English sum
mary and may, if the author wishes, carry
a more detailed summary in French.
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produce an immune response, based on
thymus-dependent immunocytes, equiv
alent to homograft rejection.
In this monograph, Prehn and Lappe
support the concept that although specific
immune reactivity may sometimes be ade
quate to control a neoplasm, lesser degrees
of immune reactivity may actually promote
growth of nascent tumours.
Possibilities for immunotherapy, the
present status of carcinoembryonic anti
gens, the relationship between suscepti
bility to the development of reticuloendo
thelial malignancy and HL-A typing, and
the increased incidence of malignant tu
mours in patients after organ transplan
tation have been reviewed in interesting
detail.
This review is recommended to anyone
who wishes a concise summary of the con
cept of immunologic surveillance against
cancer.
L .

D.

TRANSPLANTATION
REVIEWS.
8.
Immunological Tolerance. Effect of A n
tigen on Different Cell Populations.
Edited by Goran Moller. 136 pp. Illust.
Munksgaard, Copenhagen, 1972. Dan. Kr.
74,75. $10.75 (approx.). Paperbound.

This text is number 8 in a series entitled
“ Transplantation Reviews” and consists
of five comprehensive articles written
by authorities on various aspects of im
munologic tolerance. This publication will
be of greatest interest to immunologists
active in research, and to surgeons in the
field of transplantation. The monograph
is mainly concerned with cellular events
leading to a state of immunologic un
responsiveness or tolerance, with the
characteristics of this state and the
cellular changes that occur when the
tolerant state terminates.
L. D . M aclean

M aclean

Royal Victoria Hospital,
Montreal, Que.

Royal Victoria Hospital,
Montreal, Que.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal
devra porter la mention “Le journal canadien
de chirurgie” et etre adressee a l’Editeur, P.O.
Box 8650, Ottawa, Ontario K1G 0G8.
Le journal est publie a tous les deux mois.
Le prix de l’abonnement est de $15. par an
($7.50 par an pour les medecins qui sont resi
dents en chirurgie) et commence avec le nu
mero de janvier de chaque annee. Un exemplaire isole coute $2.50 et est payable d’avance.
IN STRUCTIONS A NOS
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap
ports cliniques etc. seront envoyes en deux
exemplaires, accompagnes d’une lettre deman
dant qu’on veuille bien considerer leur publica
tion dans L e journal canadien d e chirurgie. Ils
ne seront acceptes qu’a la condition qu’ils
n’aient ete soumis qu’a notre Journal et qu’ils
ne soient pas reimprimes sans le consentement
expres de l’editeur et l’auteur. L ’acceptation
ou le refus des articles soumis releve du Conseil de la publication. Si la place est disponible,
un nombre limite d’histoires cliniques pourront
etre publiees. Les articles seront dactylographies
sur un seul c6te d’un papier non ligne, a dou
ble espace et avec une large marge. L ’auteur
devra toujours conserver une copie au papier
carbone du texte soumis. Tout article devra
etre accompagne d’un resume. L ’orthographe
sera celle adoptee par le dictionnaire Larousse.
Quant a la terminologie scientifique, elle sera
basee sur le Dictionnaire des termes techniques
de medecine ou tout autre ouvrage de refe
rence serieux. Le Conseil de la publication se
reserve le droit d’apporter au texte les changements qu’il jugerait a propos pour assurer la
correction grammaticale et l’orthographe, pour
eliminer d’eventuelles obscurites ou pour rendre la presentation conforme au style du Jour
nal canadien d e chirurgie. Aucun changement
important ne sera apporte au texte sans que
l’auteur ait ete prealablement consulte. Les
auteurs recevront avant la publication des
epreuves d’imprimerie de leur texte, auxquelles
ils sont pries d’apporter le minimum de correc
tions.
Tires-d-part
On pourra commander des tires-a-part sur
une formule qui est envoyee avec les epreuves.
11 est important de les commander avant la
publication de l’article, sous peine de devoir
payer un supplement pour une nouvelle com
position.

Bibliographie
Les references bibliographiques seront indiquees par des numeros dans le corps du texte.
Elies comprendront dans l’ordre: le nom de
hauteur et ses initiales, en majuscules, le titre
abrege du Journal, le numero du volume, le
numero de la page et l’annee. Les abreviations
admises pour les noms de revues sont celles qui
figurent dans I’index Medicus. Les renvois aux
livres comprendront dans l’ordre: le nom de
l’auteur, ses initiales, le titre de l’ouvrage, le
numero de l’edition (p. ex. deuxieme ed.), la
ville et le nom de la maison d’edition, et
l’annee de la publication; enfin, le numero de
la page s’il s’agit d’un renvoi precis. Pour
exemples, voyez Tissue de janvier 1971 et ceux
a venir.
Illustrations
Le journal accepte de publier gratuitement
un nombre raisonnable d’illustrations en noir
et blanc. Les reproductions de cliches en couleurs seront publies aux frais de l’auteur. Les
photographies seront imprimees sur papier brillant, ne seront ni montees ni calibrees et d’un
format maximum de 6" x 8". En ce qui concerne les radiographies, nous demandons des
copies et non pas Voriginal. On devra toujours
fournir un agrandissement de microphotogra
phies. II ne faut jamais ecrire ou dactylographier un texte quelconque sur les photogra
phies. Une legende les identifiant pourra etre
jointe au dos. Dans les illustrations montrant
des malades, ceux-ci ne pourront etre reconnus,
a moins qu’ils n’en aient donne le consentement
ecrit prealablement a la publication. Les graphiques et diagrammes seront dessines a l’encre de Chine sur un bon papier a dessin blanc.
Le lettrage devra etre ecrit en caracteres assez
grands pour que, apres reduction proportionnelle au format du Journal, ils soient encore
lisiblesv Les legendes devant accompagner les
illustrations seront dactylographiees sur une
feuille independante du texte. Les illustrations
ne seront ni roulees ni pliees.
Langue vehiculaire
II doit etre clairement etabli que les collaborateurs ont pleine liberte de soumettre leurs
articles en frangais ou en anglais, a leur choix.
L ’acceptation de l’article sera entierement inde
pendante de la langue choisie par l’auteur. Si
le collaborateur le desire, il peut decrire le
contenu de l’article en un sommaire ne depassant pas 300 mots et dans une langue differente
de la langue choisie pour 1’article lui-meme.
Par exemple, un article ecrit en framjais doit
comporter un resume en franjais et peut, si
l’auteur le desire, etre accompagne d’un som
maire plus detaille en anglais.
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Paperbound.
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fects. Stephen Wood Gray and John Elias
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Company, Philadelphia; W. B. Saunders
Company Canada Limited, Toronto, 1972.
$37.10.
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tory, Pathology, Diagnosis, Treatment. Phi
lip Sandblom. 146 pp. Illust. Charles C
Thomas, Publisher, Springfield, 111.; Mc
Graw-Hill Ryerson Limited, Toronto, 1972
$19.75.
The Human Spine in Health and Disease.
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American edition translated and edited by
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Stratton, Inc., New York; Longman Canada Limited, Toronto, 1971. $43.70.
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Edited by Robert E. Condon and Lloyd M.
Nyhus. 385 pp. Illust. Little, Brown and
Company, Boston; J. B. Lippincott Company
of Canada Ltd., Toronto, 1972. $7.95. Paperbound.
Orthopaedic Surgery in Spasticity. Harold M.
Frost. Orthopaedic Lectures, Volume I. 216
pp. Illust. Charles C Thomas, Publisher,
Springfield, 111.; McGraw-Hill Company of
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6th ed. John Crawford Adams. 312 pp. Illust.
Churchill Livingstone, Edinburgh; Longman
Canada Limited, Toronto, 1972. $8.00.
Plastic and Reconstructive Surgery of the Face
and Neck. Proceedings of the First Inter
national Symposium. Edited by John Conley
and John T. Dickinson. Volume 1: Aesthetic
Surgery. 252 pp. Illust. Volume 2: Rehabili
tative Surgery. 368 pp. Illust. Georg Thieme
Verlag, Stuttgart; Grune & Stratton, Inc.,
New York, 1972. $54.00.
Scar Tissue. Its Use and Abuse. The Surgical
Correction of Deformation Due to Hyper
trophic Scar and the Prevention of Its For
mation. J. J. Longacre. 170 pp. Illust. Charles
C Thomas, Publisher, Springfield, 111.;
McGraw-Hill Ryerson Limited, Toronto,
1972. $18.50.

Surgical Emergencies in the Newborn. J. Alex
Haller, Jr. and James L. Talbert. 153 pp.
Illust. Lea & Febiger, Philadelphia; The
Macmillan Company of Canada Limited, To
ronto, 1972. $15.50.
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Tissue Typing Today. Proceedings of an Inter
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Transplantation February 23-25, 1971, Paris,
France. Edited by Felix T. Rapaport and
Jean Dausset. 146 pp. Illust. Grune & Strat
ton, Inc., New York; Longman Canada Lim
ited, Toronto, 1971. $17.00.
Transplantation Genetics of Primates. Edited
by Hans Balner and Jon J. van Rood. 152
pp. Illust. Grune & Stratton, Inc., New York;
Longman Canada Limited, Toronto, 1972.
$14.70.
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f o r c lin ic a l
a p p lic a t io n s

•

• Designed for clinical O.R.
or cath lab use
• Easily applied handletype probe
• Patient safety assured
through isolation circuitry
• Simple to operate minimum controls - direct
meter readout in milliliters
per minute

Biotronex Laboratory has eliminated
the guesswork in evaluating the effective
ness of an aorto coronary vein bypass.
The BL-603 Clinical Blood Flowmeter
provides a simple, yet effective method
of determining graft patency prior to
surgical closure.
The BL-603 is not a new instrument;
it is simply an extension of a device
which has been thoroughly proven in
hundreds of research applications
throughout the world. It is depend
able; designed to highest safety
standards; simple in operation; precise
in measurement - a complement to
modern day cardio-vascular surgery.

Biotronex Laboratory, Inc.
9153 Brookville Road

Silver Spring, Maryland 20910

Phone: 301/588-6400

